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PREFACE 
The present work is a publication-based dissertation based on two original manuscripts. Article 1 
is published in the “European Journal of Pain” (Shaygan, Böger, Kröner-Herwig, 2013). The 
second article is accepted for publication in the journal of “Neuropsychiatric Disease and 
Treatment”. 
Article 1 
Shaygan, M., Böger, A., Kröner-Herwig, B. (2013). Clinical features of chronic pain with 
neuropathic characteristics: A symptom-based assessment using the Pain DETECT 
Questionnaire. Eur J Pain, 17 (10), 1529-38. 
Article 2 
Shaygan, M., Böger, A., Kröner-Herwig, B. (accepted). Neuropathic sensory symptoms: 
Association with pain and psychological factors. Neuropsychiatric Disease and Treatment. 
Both studies—using independent samples—were carried out in cooperation with Clinic for Pain 
Management at the Red Cross Hospital in Kassel. The studies were supervised regarding design, 
statistical analysis and publication by Professor Dr. B. Kröner-Herwig. The author of this 
dissertation played the dominant role regarding (a) the idea and development of study design, (b) 
the collection of data, (c) the statistical analysis and interpretation of data, and (d) the preparation 
for publication of manuscripts. In order to integrate the articles into a larger context, the 
following text provides common theoretical background and the objectives of the individual 
studies. Methods, main results and conclusions of each study will be summarized, followed by a 
joint discussion of both studies. In the second part of the dissertation, the two original articles are 
provided. 
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Chronic pain conditions are often categorised into two major groups, namely nociceptive 
(caused by tissue damage) or neuropathic (caused by nerve damage) pain. In the past few years, 
this dichotomous approach (either neuropathic or nociceptive) has been questioned and it has 
been suggested that not only “typical” neuropathic pain syndromes but also otherwise chronic 
pain (e.g. back pain) may have neuropathic components of pain. This dimensional perspective is 
consistent with basic scientific opinion regarding chronic pain mechanisms; however, further 
studies are needed to examine it empirically. Neuropathic symptoms (e.g. burning and prickling 
sensations) have a central role in the clinical diagnosis of the neuropathic components of pain. 
The main aim of the first study was to assess the severity of self-reported neuropathic symptoms 
in different syndromes of chronic pain (e.g. headache, musculoskeletal pain, postsurgical pain).  
Using validated screening tools for neuropathic symptoms, a number of recent population-
based studies reported higher levels of pain intensity, as well as anxiety and depressive 
symptoms, in respondents who scored high on neuropathic symptoms, compared to those who 
scored low. Consequently, many authors have suggested the assumption of the uniqueness of 
neuropathic pain quality in its intensity and distressing characteristic. We aimed to further 
examine the association of the severity of neuropathic symptoms with pain-related (e.g. pain 
intensity and chronicity) and psychological factors (e.g. depression) in clinical samples of 
patients: one sample of patients with diverse types of chronic pain (study 1), and 4 samples of 
patients with typical neuropathic pain, radiculopathy, fibromyalgia or nociceptive back pain 
(study 2). In study 2, we also compared different patterns of neuropathic symptoms regarding 
pain and psychological factors.  
Seven hundred and six (study 1: n=400; study 2: n=306) patients suffering from a chronic 
pain condition enrolled for multidisciplinary pain treatment were considered for inclusion in the 
research project. The criteria for inclusion were: an age of over 18 years and having chronic pain 




according to ICD-10 criteria (F45.41 or R52.1-2). In study 2 only patients with typical 
neuropathic pain, back pain with (radiculopathy) or without (nociceptive back pain) clinical 
signs of nerve involvement, and fibromyalgia were included. The pain DETECT questionnaire 
was used to assess the severity of neuropathic symptoms in patients.  
A high severity of neuropathic symptoms was found not only in “typical neuropathic pain” 
but also in fibromyalgia and postsurgical pain (study 1).  
At first sight, our findings in a sample of patients with diverse types of chronic pain (study 1) 
suggested that neuropathic symptoms are associated with a high level of pain intensity, pain 
chronicity, functional disability and depression. However, in study 2 considering patients who 
had been diagnosed with typical neuropathic pain, radiculopathy or fibromyalgia, neither 
severity nor different patterns of neuropathic symptoms were correlated with the pain-related and 
psychological variables. A subgroup of nociceptive back pain patients who scored high on self-
reported neuropathic symptoms reported high levels of pain intensity, depression, catastrophising 
and non-acceptance of pain suggesting a general response tendency (response bias) in this 
subgroup of nociceptive back pain patients.  
In summary, the results corroborate and support a dimensional perspective of neuropathic 
pain. Our findings lend no support to the assumption of many authors that a high severity of 
neuropathic symptoms principally results in high levels of pain intensity and psychological 
distress as it is not the case in patients with an underlying pathology of neuropathic symptoms. 
The results highlight the influence of cognitive-emotional factors on the experience and report of 









I. Synopsis of publications 
1. Introduction 
Chronic pain is a widespread disabling health problem. In an epidemiological study by 
Breivik, Collett, Vittorio, Cohen and Gallacher (2006), the prevalence of chronic pain, defined as 
pain lasting more than 6 months, occurring several times during the last week, with an intensity 
of 5 or more on a numeric rating scale (0–10) for the last episode of experienced pain, was 19% 
in adult Europeans. Chronic pain is frequently associated with reduced capacity to work (Breivik 
et al., 2006) and it has a dramatic impact on the lives of affected individuals and a substantial 
economic impact on society. 
Chronic pain conditions are often categorised into two major groups, namely, nociceptive and 
neuropathic pain (Woolf et al., 1998). Nociceptive pain has been defined as ‘Pain that arises 
from actual or threatened damage to non-neural tissue and is due to the activation of 
nociceptors’ (International Association for the Study of Pain, 2011). Nociceptive pain is 
commonly described as deep, dull, throbbing, cramping and aching in its quality (Victor, Jensen, 
Gammaitoni, Gould, White, & Galer, 2008). 
1.1 Neuropathic pain: definition, classification, aetiology and epidemiology  
Neuropathic pain, often called “typical neuropathic pain”, has been recently redefined as 
‘pain caused by a lesion or disease affecting the somatosensory system’ (Treede et al., 2008). 
This definition replaced the old definition of neuropathic pain (Merskey & Bogduk, 1994), 
which defined it as ‘pain initiated or caused by a primary lesion or dysfunction of the nervous 
system’. The term “somatosensory system” replaces the previous term “nervous system” to 
distinguish neuropathic pain from pain caused by lesions in other parts of the nervous system, 
such as the central motor pathways, e.g., pain associated with spasticity and rigidity (Jensen et 
al., 2011). Moreover, the term “disease” replaces the previous term “dysfunction”, which may 
erroneously be interpreted as the normal plasticity of the nociceptive system. This means that 
dysfunction without evidence of injury is no longer regarded as meeting the criteria for 




neuropathic pain (Bennett, 2010). Thus, dysfunctional pain conditions without any identifiable 
nerve lesion, such as fibromyalgia, should not be categorised as neuropathic pain (Treede et al., 
2008). Fibromyalgia is a chronic painful syndrome that is characterised by abnormal pain 
sensitivity (e.g., hyperalgesia) and widespread pain (Staud, 2011). Although in the majority of 
fibromyalgia patients, no nerve lesions can be demonstrated, sensory dysfunctions in these 
patients can be explained in terms of other pathogenic mechanisms, such as a dysfunction of the 
endogenous systems modulating afferent activity (Bradley et al., 2002; Kosek et al., 1996; 
Uceyler et al., 2013). 
Depending upon the location of a nerve injury, neuropathic pain is commonly classified as 
central (originating from damage to the brain or spinal cord, e.g., multiple sclerosis, post-stroke 
pain) or peripheral (originating from damage to the peripheral nerve, plexus, dorsal root 
ganglion, or root, e.g., diabetic polyneuropathy and post-herpetic neuralgia; Haanpää & Treede, 
2010).  
Many common diseases, injuries, and interventions may cause neuropathic pain by producing 
lesions in the somatosensory pathways in the peripheral or central nervous system. The most 
common causes of neural damage and subsequent pain are metabolic disease (e.g., diabetes), 
infection (e.g., herpes zoster), trauma (e.g., spinal cord injury), ischemia (e.g., post-stroke pain), 
surgery and tumor infiltration (Dworkin, 2002). Because of the large number of underlying 
causes of neuropathic pain and the lack of standardised measurement methods for identifying the 
neural damage, the overall prevalence of neuropathic pain syndromes in the general population is 
difficult to quantify (Freynhagen & Bennett, 2009; Haanpää & Treede, 2010).  
However, a number of studies have examined the epidemiology of the important specific 
causes of neuropathic pain. For example, one prospective study of the first five years following 
spinal cord injury indicated that, after a spinal cord injury, 41% of individuals had neuropathic 
pain at the level of the injury (Siddall, McClelland, Rutkowski, & Cousins, 2003). The incidence 




of postherpetic neuralgia (PHN) ranges from between 25% and 50% of patients affected by 
herpes zoster at three months after rash onset (Schmader, 2002). The point prevalence of diabetic 
peripheral neuropathy (DPN) was found to be 26.4% among patients with type 2 diabetes 
(Davies, Brophy, Williams, & Taylor, 2006).  
1.2 Clinical presentations of neuropathic pain: a different pain quality from nociceptive 
pain 
Clinically, neuropathic pain is characterised by a complex pattern of abnormal sensory 
symptoms, including positive and negative sensory symptoms. Positive sensory symptoms 
reflect an abnormally high level of excitability or disinhibition in the somatosensory system and 
include spontaneous pain and stimulus-dependent pain. Spontaneous pain occurs in the absence 
of any stimulation and is commonly described by patients as burning, shooting or “electric-like” 
in quality. Stimulus-dependent pain includes allodynia (i.e., pain in response to a non-painful 
stimulus) and hyperalgesia (i.e., increased pain sensitivity to a painful stimulus) (Baron, Binder, 
& Wasner, 2010).  
Negative sensory symptoms in neuropathic pain may result from a partial or complete loss of 
impulse conduction in the neural tissues and include hypoesthesia (decreased sensitivity to 
stimulation), hypoalgesia (diminished pain in response to a normally painful stimulus) and 
analgesia (absence of pain in response to stimulation that would normally be painful) (Gilron, 
Watson, Cahill, & Moulin, 2006). 
1.3 A dimensional perspective on neuropathic pain 
In the past few years, the dichotomous approach classification of chronic pain (either 
neuropathic or nociceptive) has been questioned and it has been suggested that chronic pain may 
be better conceptualised as a spectrum, in which pain may have more or less neuropathic 
components (Bennett, Smith, Torrance, & Lee, 2006; Bennett, 2010). Consequently, one other 




category of chronic pain, i.e., “mixed pain”, which is defined as a syndrome with both 
nociceptive and neuropathic components of pain, has been considered (Freynhagen & Baron, 
2009). The combination of nociceptive and neuropathic pathological mechanisms of pain is 
particularly supposed in radicular back pain (radiculopathy) (e.g., Freynhagen & Baron, 2009) 
and postsurgical pain (e.g., Shaladi, Saltari, Crestani, & Piva, 2009). Radiculopathy is thought 
to be caused by lesions of nociceptive sprouts or mechanical compression of nerve roots within 
the degenerated disc (Baron & Binder, 2004). Also, long-term postsurgical pain probably 
results from surgical injury to peripheral nerves (Schaladi et al., 2009). While “typical 
neuropathic pain” conditions (e.g., diabetic polyneuropathy and post-herpetic neuralgia) 
generally do not provide serious diagnostic difficulties, it is more difficult to detect a neuropathic 
component in “mixed pain” conditions like radicular back pain (Attal & Bouhassira, 2004). 
Nevertheless, differentiation between nociceptive and neuropathic components of pain is 
clinically important and has a direct impact on therapeutic decisions about pain: Anticonvulsants 
and antidepressants are predominantly pharmacological treatment options for neuropathic pain, 
whereas nociceptive pain is sensitive to non-steroidal anti-inflammatory drugs (NSAIDS) 
(Freynhagen & Bennett, 2009; Haanpää & Treede, 2010).   
1.4 Screening tools for neuropathic symptoms  
The definition of neuropathic pain (Treede et al., 2008) seems to be easily applicable, but in 
fact, it describes a mechanism-based diagnosis of pain, which can hardly be verified. Pain 
patients typically present a complex pattern of self-report symptoms rather than recognisable 
neurological lesions or definable mechanisms (Bennett, Attal, Backonja, Baron, Bouhassira, 
Freynhagen et al., 2007). Hence, the lack of objective markers, as well as the lack of a gold 
standard for the detection of neuropathic pain makes the identification of neuropathic 
components of pain a continuing challenge for clinicians (Haanpää et al., 2011; Torrance, Smith, 
Watson, & Bennett, 2007). Nevertheless, the separation of the neuropathic components of pain 
from those that are non-neuropathic has direct implications for treatment strategies. Hence, it is 




of the high importance for the clinician to identify the presence of different pain components 
(i.e., nociceptive, neuropathic or both) to select adequate treatments in each individual patient 
(Freynhagen & Bennett, 2009; Haanpää & Treede, 2010). Techniques such as quantitative 
sensory testing, functional imaging and skin biopsies are tools that provide valuable information 
about the neurobiology of pain. However, these investigations are expensive and require a level 
of technical expertise that is only obtainable at a few highly specialised centres (Scholz et al., 
2009). Additionally, many clinicians in both primary and secondary care do not have the 
adequate skill or time for a thorough neurological examination (Bennett et al., 2007). Therefore, 
the examination of symptoms assessed by self-report has became a major focus in the assessment 
of neuropathic pain.  
The results of the study by Boureau, Doubrere and Luu (1990) provided evidence that six 
sensory symptoms, i.e., burning, coldness, tingling, prickling, itching and “electric-like” 
sensations, are more frequently chosen by patients with “typical neuropathic pain” syndromes. 
Moreover, although still under discussion, some recent studies suggest that the pattern of 
neuropathic symptoms provides a guide to the underlying mechanisms of pain that optimises the 
treatment of pain (Baron et al., 2010; Baron, Tölle, Gockel, Brosz, & Freynhagen, 2009; Baron, 
2006; Dworkin, 2002). Hence, efforts have been recently undertaken to develop symptom-based 
screening tools to help to assess “pain with neuropathic characteristics”, i.e., pain with distinct 
neuropathic symptomatology (e.g., Freyhagen, Baron, Gockel, & Tölle, 2006). One feature that 
is common to all of these tools is a reliance on verbal descriptors of pain quality. Although 
screening tools can be a guide to identify patients with neuropathic pain, they seem to fail to 
identify about 10-20% of patients with clinically diagnosed neuropathic types of pain and thus do 
not replace clinical judgement (Bennett et al., 2007). 
Pain DETECT Questionnaire: 




One of the five validated screening tools, the so-called Pain DETECT Questionnaire (PDQ, 
Freynhagen, Baron, Gockel, & Tölle, 2006a), was developed to detect neuropathic pain 
components in chronic low back pain and in “typical neuropathic pain” syndromes. The PDQ is a 
self-report questionnaire consisting of nine items that ask about the intensity and quality of pain 
with a total score ranging from -1 to 38. The questions address the presence of seven sensory 
symptoms rated on a 0–5 rating scale (never to very strong):  
1. burning pain, 
 2. paresthesias,  
3. mechanical allodynia,  
4. spontaneous pain attacks,  
5. thermal hyperalgesia,  
6. numbness,  
7. pressure hyperalgesia.  
The PDQ also comprises two questions regarding the course of pain and the radiation of pain: 
1. Please select the picture that best describes the course of your pain. 
─ Persistent pain with slight fluctuations 
─ Persistent pain with pain attacks 
─ Pain attacks without pain between them 
─ Pain attacks with pain between them 
2. Does your pain radiate to other regions of your body? Yes/No 
It was validated in a sample of patients with either neuropathic pain, including post-herpetic 
neuralgia, polyneuropathy, nerve trauma and low back pain (LBP in which the source of pain is 




in the lumbar vertebrae, sacrum and/or coccyx) or nociceptive pain, including visceral pain, 
osteoarthritis, inflammatory arthropathies and non-neuropathic LBP. The instrument categorises 
the patients into three groups: Neuropathic, non-Neuropathic, Unclear. The questionnaire 
demonstrated good internal consistency (Cronbach’s alpha= 0.83; Freynhagen et al., 2006a).  
1.5 The association of neuropathic symptoms with pain-related parameters and 
psychological distress 
Consistent with the general literature on chronic pain, there is strong evidence of the negative 
impact of neuropathic pain on patients and society. Neuropathic pain can result in psychological 
distress (defined as a state of emotional suffering characterised by symptoms of depression and 
anxiety; Mirowsky & Ross, 2002), physical disability, reduced quality of life, and increased 
health care costs (Dworkin, 2002; Freynhagen & Bennett, 2009; Haanpää et al., 2011; Haanpää 
& Treede, 2010).  
After the development of standardized screening tools for neuropathic symptoms, a number 
of population-based studies (postal questionnaire surveys) in non-clinical samples reported a 
higher level of pain intensity as well as anxiety and depressive symptoms in respondents who 
scored high on neuropathic symptoms, compared to those who scored low (e.g., Attal, Lanteri-
Minet, Laurent, Fermanian, & Bouhassira, 2011; Bouhassira, Lantéri-Minet, Attal, Laurent, & 
Touboul, 2008; Freynhagen et al., 2006a; Smith, Torrance, Bennett, & Lee, 2007; Torrance, 
Smith, Bennett, Lee, 2006). Despite the fact that the diagnosis of chronic neuropathic pain was 
not clinically evaluated in participants in these population-based studies, many authors 
generalised these findings to chronic clinical neuropathic pain. They concluded that the 
neuropathic quality of pain is of higher intensity and unpleasant than the nociceptive pain and 
that it results in more psychological distress in patients. Similar results were documented in a 
survey by Attal and colleagues (2011), who found a lower level of quality of life and a greater 
use of health care facilities in subjects who scored high on neuropathic symptoms. They 
suggested that “it is the particular features, the strange and unpleasant signs and symptoms of 




this type of pain, and the distressing and unpleasant nature of the neuropathic symptoms 
themselves that impact on quality of life”.  
The assumption, that the neuropathic pain is more intense and distressing than the 
nociceptive pain, has been repeatedly iterated in a large number of literature available in this 
field (e.g., Förster et al., 2013; Freynhagen & Bennett, 2009; Haanpää et al., 2009). However, 
there is not enough convincing evidence that supports this assumption. 
Studies concerning differences in the pain-related features and psychological characteristics 
of medically diagnosed neuropathic and nociceptive pain are rare. Daniel, Narewska, Serpell, 
Hoggart, Johnson, and Rice (2008) found that patients with postherpetic neuropathic pain and 
nociceptive back pain did not differ in their reports of depressive/anxiety symptoms, 
dysfunctional cognition (e.g., fearful appraisals of pain) and physical function. Also, some 
previous clinical studies, found no differences in pain intensity between typical neuropathic and 
nociceptive pain (e.g., Bennett, 2001; Dworkin, Jensen, Gammaitoni, Olaleye, & Galer, 2007; 
Scholz et al., 2009). Thus, studies on “comparison of patients with medically diagnosed 
neuropathic vs. nociceptive pain” and “comparison of population samples reporting pain with 
high vs. low level of severity of neuropathic symptoms” produced obviously inconsistent results 
on differences regarding pain features like general intensity and psychological distress. However, 
none of the above mentioned clinical studies examined the severity of neuropathic symptoms and 
its direct association with pain and psychological distress. 
1.6 Pain experience: the biopsychosocial perspective of chronic pain 
The earliest theories of pain focused primarily on the biological or pathophysiological 
components of pain. In 1968, Melzack and Casey described pain in terms of three dimensions, 
the "sensory-discriminative" (e.g., intensity and quality of the pain), the "affective-motivational" 
(e.g., pain unpleasantness), and the "cognitive-evaluative" (e.g., pain appraisals). They 
emphasised that pain experience is a function of the interaction of these dimensions and cannot 
be ascribed exclusively to any one of them. In consequence, in order to fully understand a 




person’s experience of pain, the interrelationships between biological, psychological, and 
sociocultural factors need to be considered. On the basis of this biopsychosocial approach, pain 
intensity and unpleasantness are not simply determined by the magnitude of the tissue damage or 
physical factors; rather, psychological factors (emotions and cognitions) also can modulate 
perceived pain intensity and unpleasantness in patients (Gatchel, Peng, Peters, Fuchs, & Turk, 
2007; Turk, Meichenbaum, & Genest, 1983).  
1.7 The effect of psychological factors on symptom report 
Pain is a subjective experience. Accumulated research has demonstrated that the report of 
subjective symptoms is influenced by several psychological factors, including negative 
affectivity and cognitive self-appraisal (Diest, Peuter, Eertmans, Bogaerts, Victoir, & Bergh, 
2005; Haythornthwaite, Sieber, & Kerns, 1991; Watson & Pennebaker, 1989; Watson & Clark, 
1984). Negative affectivity has been generally described as a tendency to experience and report a 
wide range of negative feelings, such as anxiety, hostility, depression and fear, and has been 
shown to be a rather reliable and valid psychometric construct (Clark, Watson, & Mineka, 1994; 
Diener & Emmons, 1985; Keogh & Reidy, 2000; Watson & Clark, 1984). It has repeatedly been 
found that individuals who score high on self-report questionnaires of negative affectivity also 
report high levels of many somatic symptoms as well (e.g., Costa & McCrae, 1980, 1985; 
Pennebaker, 1982).  
There are several possible explanations for this association of emotional and somatic 
conditions, including a true co-occurrence of psychological and medical illness in the same 
individual. Another possible explanation is that some individuals may have a greater tendency to 
perceive and respond to both negative psychological and physical experiences, i.e., to amplify all 
forms of distress. This general negative response tendency (response bias) is revealed by a 
dominance of responses at the negative pole of a rating scale (e.g., Deary, Chalder, & Sharpe, 
2007; Kolk, Hanewald, Schagen, & Gijsbersvan Wijk, 2002; Stea, Lee, & Sears, 2013; Watson 
& Pennebaker, 1989; Watson & Clark, 1984). However, a growing number of studies has 




suggested that there is considerable variation in how strongly reports of different symptoms are 
influenced by this response bias. For example, response bias has been suggested to be more 
influential in report of symptoms in patients without any previous experience or knowledge about 
them (Petersen, van den Berg, Janssens, & van den Berg, 2011), and with symptoms without any 
identified pathology than those that can be verified by clinical examination or medical tests (e.g., 
Cohen, William, Ronald, Cuneyt, & David, 2003; Deary et al., 2007; De Gucht, Fischler, & 
Heiser, 2004; Feldman, Cohen, Doyle, Skoner, & Gwaltney, 1999; Kisely, Goldberg, & Simon, 
1997; Kolket al., 2002). This clinical phenomenon has attracted a number of names, including 
the term “somatosensory amplification”, which refers to a predisposition to focus on certain 
weak and infrequent bodily sensations, as well as a tendency to appraise them as pathological 
and symptomatic of disease, rather than to normalise them. In this context, attentional and 
interpretational processes seem to play an important role in the mechanisms of the response bias 
phenomenon (Barsky, Goodson, Lane, & Cleary, 1988; Deary et al., 2007; Kolk et al., 2002).  
In conclusion, it is argued that not only does the character of experienced pain associated 
with somatosensory and neurologic mechanisms determine the symptom report, but also an 
individual tendency to select specific response categories, in this case, preferring the endpoints 
of a response scale independently of the item content. The negative response tendency has been 
suggested to inflate the association of somatic complaints and psychological factors (e.g. Watson 










2. Aims of the thesis 
The dimensional perspective of neuropathic pain is compatible with basic scientific opinion 
regarding chronic pain mechanisms (Backonja, 2003; Bennett et al., 2007; Freynhagen & Baron, 
2009). Further studies, however, are needed to empirically examine this perspective (Bennett, 
2010). The main directive of the first study was to further examine the dimensional perspective 
by quantitative assessment of the severity of self-reported neuropathic symptoms in diverse types 
of chronic pain (study 1). The severity of neuropathic symptoms has a central role in the clinical 
diagnosis of neuropathic components of pain, as it was depicted before. Previous research had 
generally been focused on a global dichotomous categorisation of different types of pain, i.e. 
neuropathic or nociceptive, when assessing the severity of neuropathic symptoms. So far, no 
study has explicitly analysed the severity of neuropathic symptoms in diverse types of pain, 
although this might provide a better understanding of the dimensionality of neuropathic pain, and 
help to improve the diagnosis of neuropathic pain components. The valid diagnosis of 
neuropathic pain may, in turn, provide an opportunity for adequate pain treatment.   
We further aimed to examine the association of the severity of neuropathic symptoms with 
pain-related features and psychological factors, as there has been a controversy within the 
existing literature. In the first study, we examined this association in a sample of patients with 
different types of chronic pain (study 1), as the dimensional perspective of neuropathic pain 
suggests the likelihood of a differential extent of neuropathic components in different types of 
pain. The patients were categorised on the basis of the self-reported severity of neuropathic 
symptoms and were compared regarding pain intensity, pain chronicity, pain-related disability, 
length of hospital stay and depressive symptoms. Also, the predictive strength of the mentioned 
variables regarding the neuropathic score was analysed. 




The main aim of the second study was to analyse this association within samples of patients 
particularly diagnosed as having an underlying pathology of neuropathic symptoms. We wanted 
to find out whether patients with typical neuropathic pain, radiculopathy or fibromyalgia who 
report different levels of the severity of neuropathic symptoms also differ in pain intensity, pain 
chronicity, depressive symptoms, pain catastrophising and acceptance. In study 2, we also 
compared different patterns of neuropathic symptoms regarding the above mentioned variables. 
By including patients with a “certain” neuropathic component of pain and/or neurological 
dysfunction assessed by neurological examinations in study 2, we increased the reliability of 
findings regarding the association of neuropathic symptoms with pain and psychological factors.  
As described before, response bias has been suggested to be more influential in report of 
symptoms in patients without any previous experience or knowledge about the questioned 
symptoms. Hence, we were interested in the examination of this association in a sample of 
patients clinically diagnosed with a nociceptive type of pain i.e. nociceptive back pain. This 
might provide a better insight into the observed association of neuropathic symptoms with other 
indicators of health status assessed in population, or non-selected sample of pain patients 
including both neuropathic and nociceptive pain patients (study 1), which might explain some of 












3. Summary of the original studies 
Within the research project, two studies—using independent samples—were carried out in 
cooperation with the Pain Management unit at the Red Cross Hospital in Kassel. In the following 
sections, the samples and the main results of these studies are summarised. Both studies were 
approved by the ethics committee of the Georg-Elias-Müller-Institute of Psychology. 
3.1 Summary of study 1: Clinical features of chronic pain with neuropathic 
characteristics: a symptom-based assessment using the Pain DETECT Questionnaire 
This study aimed to assess the severity of self-reported neuropathic symptoms in different 
syndromes of chronic pain and to group the syndromes according to the severity of their 
neuropathic symptoms. These groups were compared regarding pain variables like intensity and 
chronicity, as well as pain-related disability, length of hospital stay, pain history and depressive 
symptoms. The predictive strength of the above mentioned variables regarding the severity of 
neuropathic symptoms was to be analysed.  
Four hundred patients enrolled for multidisciplinary pain treatment were considered for 
inclusion in the study. The criteria for inclusion were: an age over 18 years and a diagnosis of 
chronic pain according to ICD-10 criteria (F45.41 or R52.1-2, International Statistical 
Classification of Diseases and Related Health Problems, 2012). The classification of pain 
syndromes was based on IASP Taxonomy (Turk & Rudy, 1987), using the well validated 
“Multiaxial Pain Classification System- Somatic Dimension” (MASK-S, Hildebrandt, Pfingsten, 
Maier, & Klinger, 1992; Klinger, Hasenbring, Pfingsten, Hürter, Maier, & Hildebrandt, 2000). A 
total of five primary diagnoses (i.e., headache, spinal column pain (mainly including back pain), 
musculoskeletal pain, typical neuropathic pain, postsurgical pain) were assigned. Because of the 
low numbers of patients with facial pain, ischemic pain, visceral pain and somatic unclassifiable 
pain, these diagnostic groups were collapsed into a single category, i.e., other pain.  




The severity of neuropathic symptoms in each diagnostic group was assessed by the pain 
DETECT questionnaire (PDQ, Freynhagen et al., 2006a). One-way analyses of variance 
(ANOVAs) and post-hoc Tukey's tests were conducted to explore differences between the 
diagnostic groups regarding the severity of neuropathic symptoms (PDQ score).  
According to Freynhagen et al. (2006a), the above mentioned diagnostic groups were 
recategorised on the basis of the severity of their neuropathic symptoms: Neuropathic (NP), 
non-Neuropathic (no-NP) and Unclear (UC) groups. ANOVAs and post-hoc Turkey's tests 
were performed in order to test the differences between the three groups (NP, no-NP, UC) 
regarding pain intensity, pain chronicity, disability, length of hospital stay, pain history and 
depressive symptoms. Univariate logistic regressions were applied to determine the association 
of these variables with the severity of neuropathic symptoms. The variables with a significant 
association to the severity of neuropathic symptoms were fed into a hierarchical multiple 
regression analysis. 
Our findings demonstrated the presence of distinct self-reported neuropathic symptoms in 
37% of all patients included. The validity of the PDQ score was supported by the fact that 
patients who had been clinically diagnosed with “typical neuropathic pain” scored highest on the 
PDQ (M=17.79, SD=6.38; F (5, 394)=2.26; p=0.04), being significantly higher than in three of 
the other groups, i.e., the “spinal column pain”, “headache” and “other pain” groups, with the 
exception of “musculoskeletal pain” and “postsurgical pain”.  
A high PDQ score in the musculoskeletal pain category in the present study may result from 
a high percentage of fibromyalgia patients (60%, PDQ scorefibromyalgia = 17.70) in this group in 
our sample. As mentioned earlier, similarities in neuropathic symptoms between fibromyalgia 
and “typical neuropathic pain” may be explained by pathogenic mechanisms such as impaired 
small fibre function and a dysfunction of the endogenous systems modulating afferent activity in 
fibromyalgia (Bradley et al., 2002; Kosek et al., 1996; Uceyler et al., 2013). Although there is no 




evidence of nerve injury in the majority of fibromyalgia patients and thus not fulfilling the 
criteria for typical neuropathic pain, the PDQ cannot distinguish fibromyalgia from neuropathic 
pain disorders on the basis of the neuropathic symptom score. This failing differentiation is a 
clear disadvantage for the choice of adequate treatment strategies. Furthermore, since some 
previous studies (e.g., Gormsen, Rosenberg, Bach, & Jensen, 2010; Koroschetz et al., 2011) have 
documented higher levels of pain intensity, depression and anxiety in fibromyalgia patients 
compared to neuropathic pain patients, this finding should be considered when interpreting the 
association of the severity of neuropathic symptoms with the intensity of pain and psychological 
distress in samples of chronic pain patients while not considering the proportion of fibromyalgia 
patients in the sample. 
We also found a high severity of neuropathic symptoms in “postsurgical pain” not 
significantly differing from “typical neuropathic pain”. This finding provides some support for 
the assertion that a large component of persistent pain after surgery is defined by somatosensory 
symptoms defining as neuropathic pain (e.g., Kehlet, Jensen, & Woolf, 2006; Shaladi et al., 
2009; Shipton, 2008).  
Contrasting this result, a significantly lower severity of neuropathic symptoms was found in 
“spinal column pain” compared to “typical neuropathic pain”. According to Freynhagen et al. 
(2006b), only one-third of chronic back pain patients reported three or more neuropathic pain 
symptoms. This indicates that, although in a minor proportion of patients with back pain (e.g. 
radiculopathy) neuropathic mechanisms play a distinct role regarding their pain (Mahn et al., 
2011), this is not the case in the majority of these patients and also clearly less neuropathic 
symptoms are reported.  
Altogether, these results obviously demonstrate a spectrum of expression of neuropathic 
symptoms in different syndromes of chronic pain that challenges the dichotomous classification 
of chronic pain as nociceptive or neuropathic pain. Moreover, our findings lend support to the 
notion that, although diverse types of pain are distinct in their aetiology, they share some 




similarities in the underlying pathophysiological mechanisms of pain generation (Costigan, 
Scholz, & Woolf, 2009). 
Our findings, based on a clinical sample of patients with different types of chronic pain, 
demonstrated a higher level of pain intensity and depressive symptoms in the NP and UC groups 
compared with the no-NP group. ANOVAs and post-hoc tests demonstrated also significant 
differences between each of the analysed groups (NP, UC, no-NP) regarding pain chronicity and 
disability. The length of hospital stay in the NP group was significantly higher than in the no-NP 
group (see original article, Table 2). No group differences were found regarding pain history. 
The results are consistent with findings in population-based studies (e.g., Attal et al., 2011; 
Freynhagen et al., 2006) but in contrast to Daniel et al. (2008), who did not find any differences 
regarding pain intensity, depressive/anxiety symptoms and physical function between patients 
with postherpetic neuropathic pain and nociceptive back pain. The following possible reasons for 
this discrepancy should be taken into account. First, the clinical characteristics of diverse types 
of chronic pain might influence the observed association. While in our study a high percentage of 
fibromyalgia patients (61%) was in the NP group, this was not the case in described clinical 
studies comparing typical neuropathic pain and nociceptive pain syndromes. Past research has 
documented the highest level of pain intensity, disability, depression and anxiety among 
fibromyalgia patients compared to other chronic pain patients, even those with neuropathic pain 
(e.g., Gormsen et al., 2010; Koroschetz et al., 2011), whatever the cause for this phenomenon 
might be. Thus, it is necessary to examine the association of neuropathic symptoms with the pain 
and psychological factors in specific diagnostic groups like fibromyalgia, separately. 
Second, the possibility of response bias should be considered. As noted before, not only does 
the character of experienced pain associated with biological mechanisms determine the symptom 
report, but also cognitive, emotional and behavioural factors. The contribution of the 
psychological factors to the symptom report is more likely when patients do not have any 
identified pathology (Deary et al., 2007) or previous experience or knowledge about the 




questioned symptoms. Based on clinical experience, the questioned symptoms in Pain DETECT 
Questionnaire like “is cold or heat (bath water) in this area occasionally painful?” or “do you 
have sudden pain attacks in the area of your pain, like electric shocks” were unfamiliar for many 
patients who had no previous experience about them. It is possible that some of these patients 
having a high level of negative affectivity (e.g. depression) and negative cognitive appraisals 
(e.g. pain catastrophizing) (mis)interpret and (mis)attribute rather inconspicuous sensations in the 
manner of the questioned neuropathic symptoms, inflating correlations among neuropathic 
symptoms and cognitive-emotional factors (e.g. depression). To gain a more precise insight 
regarding the association of neuropathic symptoms with pain and psychological factors, it should 
be analysed in a sample of patients who have been medically diagnosed with neuropathic 
components of pain (e.g. typical neuropathic pain syndromes).  
In summary, the results of study 1 support the questioning of the dichotomous classification 
of chronic pain since a high severity of neuropathic symptoms was found in other diagnoses, 
particularly, in fibromyalgia (as a dysfunctional pain condition) and postsurgical pain (as a 
mixed pain syndrome). Chronic pain patients who scored high on self-reported neuropathic 
symptoms also reported high levels of pain intensity, pain chronicity, depression and functional 
disability. These findings provide some support for the common assumption that the neuropathic 
quality of pain is experienced and reported to be more intense and distressing than the pain 
without this specific quality. Whether this phenomenon is mainly based on the biological 
mechanisms of pain (neuropathic/nociceptive) or on other factors of pain processing so far 
remain obscure.  
3.2 Summary of study 2:  Neuropathic sensory symptoms: Association with pain and 
psychological factors 
Our findings from study 1 provided some preliminary evidence for the common assumption 
that the neuropathic quality of pain is associated with more intense pain and distress in patients. 




However, neither prior studies nor our first study medically evaluated specially regarding the 
presence of neuropathic components of pain in (all) patients who scored high on neuropathic 
symptoms.  
The main aim of the second study was to examine the association of neuropathic symptoms 
with pain-related features and psychological factors in patients who had been diagnosed as 
having an underlying pathology of neuropathic symptoms.  
In doing so, we first assessed self-reported neuropathic symptoms by the PDQ in patients 
with a clinical diagnosis of “typical neuropathic pain” (TNP), “radiculopathy” (RAD), 
“fibromyalgia” (FM) or “nociceptive back pain” (nBP). Cluster analysis was used to classify 
patients of each diagnostic group according to the self-reported severity of neuropathic 
symptoms (clustering 1). The association of the severity of neuropathic symptoms with pain-
related parameters like pain intensity and chronicity, as well as psychological factors 
(depression, catastrophising, pain acceptance) in each of the four aforementioned diagnostic 
groups (i.e., TNP, RAD, FM and nBP) was determined.  
In order to control for the response bias, a second clustering approach (clustering 2) was 
performed based on adjusted scores of neuropathic symptoms; relating actual responses to the 
individual mean responses. This means that the patient’s rating of each item was subtracted from 
his/her individual mean of all seven items. This procedure is assumed to eliminate the response 
bias of patients (Baron et al., 2009; Elliott, Haviland, Kanouse, Hambarsoomian, & Hays, 2009). 
The adjusted scores, also, enabled us to categorise the patients of the different diagnostic groups 
in regard to their distinct patterns of neuropathic symptoms. The different patterns of 
neuropathic symptoms were compared regarding the above mentioned pain and psychological 
variables. 
Three hundred and six patients (an independent sample from study 1) suffering from a 
chronic pain condition who were enrolled for multidisciplinary pain treatment were considered 




for inclusion in the study. The criteria for inclusion were: an age over 18 years and having 
chronic pain according to ICD-10 criteria (F45.41 or R52.1-2, International Statistical 
Classification of Diseases and Related Health Problems, 2012). Chronic pain conditions included 
TNP syndromes (including peripheral and central neuropathic pain), RAD, FM or nBP that had 
been diagnosed by pain specialists based on history, clinical examination and further medical 
tests. Neuropathic sensory symptoms were again assessed by the Pain DETECT Questionnaire 
(PDQ, Freynhagen et al., 2006a). 
As noted, to distinguish subgroups of patients with different levels of severity of self-reported 
neuropathic symptoms, a hierarchical cluster analysis including the seven scores of symptoms 
taken from the PDQ was performed (clustering 1). Multinominal regression analysis was used to 
examine the identified clusters as predictors of diagnostic groups (criterion). To investigate 
differences between these clusters regarding pain-related and psychological variables, ANOVAs 
were calculated (separately for each diagnostic group).  
A further hierarchical cluster analysis (clustering 2) was conducted on the basis of adjusted 
scores. To explore the frequency of different diagnostic groups in each cluster, Chi-square tests 
were performed. ANOVAs assessed the differences between the identified clusters regarding the 
pain and psychological variables. 
Clustering 1 identified three distinct clusters characterised by either a low, moderate or high 
level of severity of self-reported neuropathic symptoms that differed significantly from one 
another. The 3 clusters distinguished TNP from nBP, but not from RAD and FM. Radiculopathy 
is considered as back pain with both neuropathic and nociceptive components of pain (e.g., 
Freynhagen & Baron, 2009). As described, the presence of a high level of neuropathic symptoms 
in fibromyalgia is considered as a result of altered sensory processing that can be detected by 
functional imaging (Staud, Craggs, Perlstein, Robinson, Price, 2008). The identified severity-
clusters (low, moderate or high) did not differ regarding pain intensity and chronicity, 
depression, pain acceptance and catastrophising in TNP, RAD and FM (see original article, 




Table 3) but only in nBP. Thus, in patients who had been medically diagnosed with typical 
neuropathic pain, radiculopathy or fibromyalgia, an association of severity of neuropathic 
symptoms with the intensity of pain and psychological distress could not be supported. This 
indicates that the severity of neuropathic symptoms alone is not sufficient to produce a high level 
of pain intensity and psychological distress in patients.  
There was a subgroup of nociceptive back pain patients who scored high on neuropathic 
symptoms. Significant differences between the 3 severity-clusters were found regarding nearly 
all variables with the exception of pain chronicity (see original article, Table 3). This finding 
suggests a general response tendency in those nociceptive back pain patients who scored high on 
neuropathic symptoms. As noted, past research has documented a close relation between 
negative affectivity and a higher level of reports of somatic symptoms, in particular, those 
symptoms whose respondents did not have any previous experience with or knowledge about 
them (Kolk et al., 2002; Watson & Clark, 1984; Watson & Pennebaker, 1989). Watson and 
Pennebaker, (1989) particularly pointed out that the negative response tendency inflates the 
association of somatic complaints and psychological factors. These findings underline the 
importance of considering a comprehensive assessment of pain qualities experienced by both 
groups of patients (i.e., neuropathic and nociceptive) when investigating the association of 
neuropathic symptoms with other indicators of health status. 
The cluster analysis based on the adjusted neuropathic scores led to a four-cluster solution 
with distinct patterns of symptoms (see original article, Figure 1). This approach offered a good 
opportunity to illustrate the different qualities of pain. For example, whereas one cluster (cluster 
1) was characterised by a high severity of prickling sensations, numbness and pain attacks, the 
other one (cluster 4) was identified by a severe burning pain, thermal hyperalgesia and also pain 
attacks. None of the symptom patterns was exclusively seen in any of the 4 diagnostic groups. 
Nevertheless, the distribution of the patterns differed largely between diagnostic groups. For 




instance, symptom pattern 4 occurred only in 2% of the patients with nociceptive back pain but 
in nearly 20 % of typical neuropathic pain patients. Half of the nociceptive back pain patients 
demonstrated the symptom pattern characterised by a high level of pain attacks and pressure 
hyperalgesia (cluster 2). ANOVAs showed no significant differences regarding the pain and 
psychological variables when comparing the symptom patterns. This means that neither the 
symptom patterns frequently occurring in neuropathic pain nor the symptom patterns frequently 
occurring in nociceptive back pain were associated with a higher level of pain and psychological 
distress. This finding adds evidence to question a genuine association of neuropathic quality of 
pain with high levels of pain and psychological processes. At the same time, it highlights the 
adequacy of our strategy (adjusted scores) for analysis. 
In sum, contrary to the suggestions of some authors, neither the severity of the neuropathic 
symptoms nor any pattern of these symptoms exclusively influences the intensity of pain and 
psychological distress in patients. As Melzack and Casey (1968) asserted, to consider the sensory 
features of pain as the only influential factor of perceived pain is to look at only part of the 
problem, and not even the most important part, at that. Our findings further suggest that 
individuals’ psychological and behavioural responses to pain (e.g. utilization of the health care 
system and drug taking behaviour (assessed by MPSS), depression, pain catastrophizing, pain 
acceptance) can be quite uniform, regardless of whether patients suffer from pain with high or 












Pain is an important public health problem that causes suffering and disability for many 
patients. The identification of neuropathic components of pain is of particular importance 
because this should have a direct impact on therapeutic decisions about pain (Haanpää et al., 
2011; Sykes & Beydoun, 2014). In the last decade, the dichotomous approach classification of 
chronic pain has been questioned and a dimensional perspective has been proposed. According to 
this new perspective, chronic pain is a spectrum of neuropathic expression in which the pain 
quality may reflect the relative dominance of neuropathic mechanisms in the overall pain 
experience (Bennett et al., 2006). Recently, the uniqueness of the neuropathic quality of pain, in 
its intensity, unpleasantness and psychological burden, has been suggested by many authors 
based on the results of recent population-based studies (e.g., Attal et al., 2011; Bouhassira et al., 
2008; Förster et al., 2013; Freynhagen & Bennett, 2009; Freynhagen et al., 2006a; Haanpää et 
al., 2009; Smith et al., 2007; Torrance, Smith, Bennett, & Lee, 2006). 
Our studies addressed some important gaps regarding the state of knowledge. We assessed 
the severity of self-reported neuropathic symptoms in diverse types of chronic pain, while most 
studies focused on the dichotomous categorisation of chronic pain syndromes (neuropathic vs. 
nociceptive). Hence, the present study provided a better empirical understanding of the 
dimensionality of neuropathic pain. Most importantly, we examined the prevailing assumption of 
the uniqueness of the neuropathic quality of pain in different clinical samples of patients, i.e., in 
a sample of patients with diverse types of chronic pain (study 1), as well as within each sample 
of patients medically diagnosed with “typical neuropathic pain”, “radiculopathy”, “fibromyalgia” 
or “nociceptive back pain”, separately (study 2). Furthermore, not only different levels in the 
severity of neuropathic symptoms, but also, distinct patterns in these symptoms were compared 
regarding their association with various pain features and psychological factors.  
Contrary to the dichotomous approach classification of chronic pain, a high severity of 
neuropathic symptoms was found not only in typical neuropathic pain but also in diagnoses like 




fibromyalgia (as a dysfunctional pain condition), radiculopathy and postsurgical pain (as mixed 
pain syndromes). Some researchers have argued that, although these syndromes are not allocated 
to “typical neuropathic pain”, they share some pathological mechanisms (e.g., Costigan et al., 
2009; Koroschetz et al., 2011; Mahn et al., 2010). It must be stressed that the classification of 
fibromyalgia as a variant of neuropathic pain is a subject of controversy among researchers. 
Whereas Treede et al., (2008) suggested that pain conditions without any identifiable nerve 
lesion, such as fibromyalgia, should not be categorised as neuropathic pain, Uceyler et al., (2013) 
assessing the small fibers function in fibromyalgia suggested a neuropathic nature of pain in 
fibromyalgia syndrome. Altogether, the results lend support to the questioning of the 
dichotomous approach of the classification of chronic pain as either neuropathic or nociceptive 
pain.  
At first sight, our findings in a sample of patients with diverse types of chronic pain (study 1) 
seem to support the results of population-based studies suggesting that the higher the severity of 
neuropathic symptoms, the higher the level of overall pain intensity and psychological distress 
will be. However, these results are in contrast to the results found in samples of patients 
particularly diagnosed as having an underlying pathology of neuropathic symptoms (study 2). 
Patients with typical neuropathic pain, radiculopathy or fibromyalgia who suffer from different 
levels of severity of neuropathic symptoms did not differ in the extent of pain intensity, pain 
chronicity, depression, catastrophising and pain acceptance. These findings provide compelling 
evidence that the severity of neuropathic symptoms does not principally result in a high intensity 
of pain related characteristics and psychological dysfunctional features. This can be explained by 
the fact that the experience of pain is a multidimensional phenomenon that consists of sensory, 
affective, cognitive and behavioural components, and not one of them exclusively (Turk et al., 
1983, 1998).  
A subgroup of nociceptive back pain patients who scored high on self-reported neuropathic 
symptoms also reported high levels of pain intensity, depression, catastrophising and less 




acceptance of pain suggesting a general response tendency in this subgroup of nociceptive back 
pain patients. According to Social Comparison Theory (Festinger, 1954) and Temporal 
Comparison Theory (Albert, 1977; Zell & Alicke, 2009), individuals need comparison standards 
to evaluate their opinions, skills, social status, or physical state. Petersen et al., (2011) proposed 
the comparison standards as a predictor of symptom presentations and contended that, in 
evaluating a bodily state, individuals must use reference standards, such as their personal 
experience of symptoms in the past or their beliefs about the perceptions of sensations by 
relevant others, such as patients or healthy individuals. Having no previous personal experience 
of neuropathic symptoms and a lack of knowledge about the origin and meaning of these 
symptoms among patients with nociceptive back pain may explain the biased response tendency 
regarding these symptoms, particularly among those with negative affectivity (e.g. depression) 
and cognitive self-appraisals (e.g. pain catastrophising). The finding that different levels in the 
severity of neuropathic symptoms in nBP did not differentiate pain chronicity that was not 
obtained by self-report (contrary to all other questionnaires in the second study) may provide 
additional evidence for the argument above.  
To eliminate the individual response bias regarding the neuropathic symptoms a second 
clustering approach was conducted that was based on the adjusted scores of neuropathic 
symptoms. This procedure provided a detailed insight into the different patterns of neuropathic 
symptoms. Symptom patterns that frequently occurred in typical neuropathic pain, radiculopathy 
or fibromyalgia did not show a higher level of pain and psychological distress, compared to those 
that predominantly occurred in nociceptive back pain. These findings clearly suggest that the 
assumption of the uniqueness of neuropathic pain quality in its intensity and distressing nature 
should be questioned.  
Patients who were classified in the 4 clusters were characterised by different patterns of pain 
quality. They did, however, not differ in pain intensity and chronicity, depression and 
dysfunctional cognitions. This result invalidates the assertion of some authors that “the disease 




burden of chronic pain depends on the nature of the pain, independently of its intensity and 
duration” (e.g., Attal et al., 2011; Freynhagen & Bennett, 2009). The finding can be explained by 
the fact that pain quality is only one of the factors that accounts for the pain experienced by 
chronic pain patients and it is not necessarily the most important. The results of the present study 
can be integrated well into earlier research suggesting that the psychological and behavioural 
responses to chronic pain are common to diverse samples of chronic pain patients, despite 
differences in their physical status and medical diagnosis (Turk & Rudy, 1990; Turk, Sist, 
Okifuji, Miner, Florio, Harrison et al., 1998).  
There are some limitations in regard to our findings. The current findings are based on 
samples of pain patients who sought treatment in a tertiary care center and may not be 
representative of those who attend primary care. Furthermore, our samples of patients were 
recruited from a single clinic and this selection might have affected the results. A further 
problem is that, a number of chronic pain patients suffered from two or more pain syndromes, 
but only the dominant pain complaint, as evaluated by anaesthesiologists/neurologists, was 
considered. An additional limitation relates to the main assessment instrument: the use of the 
PDQ has not been validated in fibromyalgia and headache.  
In sum, our findings seem to highlight the existence of neuropathic features in various 
diagnosed pain syndromes, which underlines the scepticism regarding a dichotomous approach 
in the classification of chronic pain. The results further suggest that the magnitude and quality of 
neuropathic symptoms alone are not sufficient to lead to a high level of pain and psychological 
distress in patients. It should be noted that these results in no way deny the contribution of the 
biological components of pain in the overall pain experienced by patients. There is little doubt 
that physical factors affect pain in patients and that treatment should include effective 
pharmacological, medical and surgical strategies. However, neglecting the importance of 
patients’ conceptualisations and evaluations of their pain may hinder the successful treatment of 
pain.  




Our findings also have several implications for studies on neuropathic pain. Particular 
attention should be paid to select syndrome specific samples of patients when investigating the 
association of neuropathic symptoms with other indicators of health status. In addition, further 
research, particularly population-based studies, should use measures that assess the pain qualities 
experienced by both neuropathic (e.g. burning pain, paresthesias, numbness) and nociceptive 
(e.g. deep, dull, throbbing) pain patients. The results also highlight the importance of using 
adjusted scores in self-report questionnaires to eliminate a potential response bias when 
investigating different self-reported symptoms. The findings further suggest that pain 
management strategies should not be based solely on the physical aspects of pain (e.g., intensity 
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Background: In general, chronic pain is categorized into two mechanism-
based groups: nociceptive and neuropathic pain. This dichotomous
approach is questioned and a dimensional perspective is suggested. The
present study investigated neuropathic characteristics in different syn-
dromes of chronic pain. We also examined the association of neuropathic
characteristics with various pain related and psychological variables.
Methods: From April 2010 to January 2012, 400 patients suffering from
a chronic pain condition enrolled for multidisciplinary pain treatment
were considered for inclusion in the study. Criteria for inclusion were age
over 18 years and having chronic pain according to ICD-10 (F45.41)
criteria. The pain DETECT questionnaire was used to assess neuropathic
characteristics of pain.
Results: Thirty-seven percent of patients with different pain diagnoses
demonstrated distinct neuropathic characteristics. The diagnostic groups for
neuropathic pain, musculoskeletal pain and post traumatic or surgical pain
showed the most neuropathic features. The level of depression, pain chro-
nicity and intensity, disability and length of hospital stay were significantly
higher in patients suffering from neuropathic symptoms. A high level of
depression and pain chronicity as well as high intensity of pain explained
most of the variance in the neuropathic scores. Disability and length of
hospital stay significantly predicted neuropathic characteristics only when
examined separately, but not if included in a common regression model.
Conclusions: Any type of chronic pain may have more or less
neuropathic characteristics. The pain-related parameters of high intensity
and chronicity as well as negative affectivity and functional disability
strongly correlate with neuropathic characteristics of pain.
1. Introduction
Chronic pain is a major health care problem in Europe
(Breivik et al., 2006). In an epidemiological study, the
point prevalence of chronic pain, defined by pain
lasting more than 6 months, occurring several times
during the last week, and last experienced pain having
an intensity of 5 or more on a numeric rating scale
(0–10), was 19% in adult Europeans. Sixty-one
percent of patients were less able or unable to work
outside the home and 19% had lost their job (Breivik
et al., 2006). Thus, chronic pain has a dramatic impact
on the lives of affected individuals and a substantial
economic impact on society.
Chronic pain conditions are often categorized
into two major groups, namely nociceptive and
neuropathic pain (Woolf et al., 1998). Clinically,
neuropathic pain is characterized by a complex
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pattern of positive (e.g., burning pain, paresthesia,
hypersensitivity) and negative (e.g., hypoesthesia,
hypoalgesia) sensory abnormalities. However, there
are still no consensual diagnostic criteria for
neuropathic pain (Haanpää et al., 2011). In contrast to
nociceptive pain, which is caused by actual tissue
damage, neuropathic pain is defined as ‘pain caused
by a lesion or disease affecting the somatosensory
system’ (Jensen et al., 2011). This definition seems to
be easily applicable, but in fact describes a mechanism-
based diagnosis of pain, which can hardly be verified
as validated. Moreover, pain patients typically present
a complex pattern of symptoms rather than recogniz-
able neurological lesions particularly in secondary
or tertiary care chronic pain populations (Bennett
et al., 2007). Hence, the lack of objective markers as
well as a gold standard for detection of neuropathic
pain (Torrance et al., 2007) makes the identification
of neuropathic pain by clinicians a continuing chal-
lenge. Recently, efforts were undertaken to develop
symptom-based, easy-to-use screening tools to help to
assess pain with distinct neuropathic symptomatology
(e.g., Bennett, 2001; Freynhagen et al., 2006a). Also,
in the past few years, the dichotomous approach clas-
sification of chronic pain has been questioned and it
has been suggested that neuropathic pain may be
better conceptualized as a spectrum, in which pain
may have ‘more or less neuropathic components’
(Attal and Bouhassira, 2004; Bennett et al., 2006).
The main aim of the present study was to assess the
neuropathic characteristics of different syndromes of
chronic pain based on patient self-reporting of pain
characteristics, and to group the syndromes according
to the level of neuropathic characteristics. These
groups were assessed regarding various variables like
intensity and chronicity of pain, pain-related disability,
depressive symptoms and length of hospital stay,
with the expectation of a higher level of severity of
the mentioned variables in patients with distinct
neuropathic characteristics. As a final step in the
analysis, we examined which variables were predic-
tive of neuropathic characteristics by regression analy-
ses. It was expected that psychological factors, besides
direct and indirect indicators of pain severity (e.g.,
intensity), contribute to the prediction of neuropathic
characteristics, and the inclusion of a psychological
variable (depression) in a multiple regression analysis
would increase the total amount of variance explained
by pain variables.
2. Methods
This cross-sectional study was conducted in a multi-
disciplinary tertiary care centre, comprising specialists in
pain medicine, psychology and neighbouring professions.
In-patients presenting with chronic pain as diagnosed by
anaesthesiologists/neurologists were requested to complete
the questionnaires presented by a hand-held computer (per-
sonal digital assistant), after having signed informed consent
regarding their participation in the study. This method of
data acquisition was validated in a study by Junker et al.
(2008). Ethical approval was obtained from the Ethics Com-
mittee of the Georg-Elias-Mueller Institute for psychology.
2.1 Sample selection
From April 2010 to January 2012, 500 patients suffering
from a chronic pain condition were referred to the pain
treatment centre. Of the 500 patients, 400 were consecu-
tively considered for inclusion in the study. Criteria for
inclusion were age above 18 years and having chronic
pain according to ICD-10 (F45.41, International Statistical
Classification of Disease and Related Health Problems, 2012)
criteria. The following exclusion criteria were set having a
pain history less than 6 months, presence of malignant
disease.
The main pain syndrome (defined as worst pain and
reported as the main reason for seeking treatment) was
assessed according to International Association for the Study
of Pain Taxonomy (Turk and Rudy, 1987) using the widely
used and well-validated Multiaxial Pain Classification
System-Somatic Dimension (Hildebrandt et al., 1992;
Klinger et al., 2000). A total of nine primary diagnoses (i.e.,
headache, facial pain, ischemic pain, spinal column pain,
musculoskeletal pain, neuropathic pain, visceral pain, post
traumatic or surgical pain, somatic unclassifiable pain, see
Supporting Information Appendix S1) based on body region
and aetiology were assigned. (Because of the low numbers of
patients with facial pain, ischaemic pain, visceral pain and
What’s already known about this topic?
• Screening instruments are easy to use and reli-
able in discriminating between patients with pre-
dominantly neuropathic versus predominantly
nociceptive pain.
• In general, researches have focused on phenom-
enological categorization when dealing with
neuropathic pain.
What does this study add?
• This study adds evidence to the characterization
of neuropathic features in otherwise diagnosed
pain.
• The neuropathic dimension of pain is character-
ized by high levels of intensity and chronicity,
negative affectivity and functional disability.
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somatic unclassifiable pain, these diagnostic groups were
collapsed into a single category, i.e., other pain).
2.2 Assessment of pain characteristics and
psychosocial variables
In addition to the standard socio-demographic assessment
(age, gender, sickness history, education and employment
status), the following variables were measured:
2.2.1 Neuropathic pain characteristics
The presence of neuropathic pain characteristics of the main
pain syndrome was assessed by the pain DETECT question-
naire (PDQ; Freynhagen et al., 2006a). The PDQ is a patient-
based (self-report) questionnaire to discriminate between
neuropathic and nociceptive pain components. The ques-
tionnaire consists of nine items and the total score ranges
from -1 to 38. It comprises questions regarding the subjec-
tive experience of a radiating quality of pain (yes/no), tem-
poral characteristics of the individual pain pattern (selection
between four pain course patterns) and the presence of
seven sensory symptoms of neuropathic pain rated on a
0–5 rating scale (never to very strongly) like spontaneous
burning sensation, prickling sensations, numbness etc. The
PDQ was validated in a study by Freynhagen et al. (2006a)
on 392 patients with either neuropathic pain (n = 167),
including post-herpetic neuralgia, polyneuropathy, nerve
trauma and low back pain (source of pain is in lumbar
vertebrae, sacrum and/or coccyx) or nociceptive pain
(n = 225), including visceral pain, osteoarthritis, inflamma-
tory arthropathies and mechanical low back pain. The
instrument indicated a sensitivity of 84% and a specificity
and probability of correct assignment of 84% in identifying
patients with distinct neuropathic characteristics of pain. As
recommended by Freynhagen et al. (2006a), the follow-
ing cut-off points were adopted as the most appropriate
for screening purposes: score  12 (< 15% chance a
neuropathic pain component is present; no-NP group);
score  19 (> 90% chance a neuropathic pain component is
likely; NP group). A score of 13–18 indicates uncertainty
regarding neuropathy (UC group). The seven items concern-
ing the presence of sensory symptoms of neuropathic pain
demonstrated adequate internal consistency (Cronbach’s
alpha = 0.83).
2.2.2 Pain intensity
The average intensity of pain was assessed on a numeric
rating scale (NRS). The NRS is an 11-point Likert scale
ranging from 0 (no pain) to 10 (worst imaginable pain). It is
an often-used reliable scale to assess intensity of pain
(Dworkin et al., 2005).
2.2.3 Chronicity of pain
Pain chronicity was estimated employing the Mainz Pain
Staging System (MPSS, Gerbershagen et al., 2002). The
MPSS assesses three stages of pain chronicity based on 10
self-administered questions (in terms of four axes). Patients
were requested to describe the occurrence of pain (e.g.,
several times per day), pain history (e.g., lasting up to several
hours) and changes in pain intensity (e.g., frequently) (tem-
poral dimension, axis 1); pain distribution (e.g., multiple sites)
(spatial dimension, axis 2); drug use (e.g., at most two non-
opioid analgesics) and number of previous drug withdrawal
treatments (e.g., more than one withdrawal) (drug taking
behaviour, axis 3); change of personal physician (e.g., no
change), pain-related hospitalizations (e.g., up to 1), pain-
related operations (e.g., up to 1) and pain-related rehabili-
tation (e.g., one) (utilization of the health care system, axis 4).
The sum of the four axes reflects an additive value in the
range of 4–12. This value determines the final stage of pain
chronicity. Stage 1 is coded when the total score ranges from
4 to 6, stage 2 is based on a range from 7 to 8 and stage 3 is
assigned when the total score is 9–12. The instrument was
validated in a study by Pfingsten et al. (2000) with 542
patients with different diagnoses.
2.2.4 Disability
Pain-related disability was measured by the Pain Disability
Index (PDI, Pollard, 1984). The PDI assesses subjective dis-
ability in seven areas: home/family responsibilities, recre-
ation, social activities, occupation, sexual behaviour,
self-care and life support activities using an 11-point scale
from ‘0’ (no disability) to ‘10’ (total disability). Thus, the
range of possible scores is 0–70. High scores reflect a high
degree of disability. In a study by Dillmann et al. (1994), the
reliability (Cronbach’s alpha = 0.88) and validity of the
German version of the instrument were confirmed. They
found a significant correlation between the PDI score and the
Oswestry Low Back Pain Disability Questionnaire (OBQ,
Fairbank et al., 1980) (r = 0.76).
2.2.5 Depression
Depressive symptoms were assessed by the Patient Health
Questionnaire for depression (PHQ-9, Spitzer et al., 1999).
Each item of the questionnaire evaluates the presence of
one of the nine DSM-IV (American Psychiatric Associa-
tion, 1994) criteria for major depression. The nine items are
answered on a 4-point rating scale ranging from ‘not at all =
0’ to ‘nearly every day = 3’. The PHQ-9 score can range from
0 to 27. The instrument demonstrated high internal consis-
tency (Cronbach’s alpha = 0.89; Rief et al., 2004). In a study
by Martin et al. (2006), the construct validity of the PHQ-9
was assessed by correlating its total score with a shortened
version of the Beck Depression Inventory (Schmitt and
Maes, 2000) (r = 0.73) and the General Health Questionnaire
(Goldberg and Williams, 1988) (r = 0.59). The German
version also showed a high sensitivity (98%) and specificity
(80%) regarding the diagnosis of a depressive disorder (Löwe
et al., 2002).
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2.3 Statistical analysis
After calculation of individual means, patients were grouped
into three categories (no-NP group: score  12; UC group:
score 13–18; NP group: score  19, see Freynhagen et al.,
2006a). One-way analysis of variance (ANOVA) and post hoc
Turkey’s test were performed in order to test the differences
between the three defined groups regarding pain intensity,
pain chronicity, depression, disability, pain history and
length of hospital stay. Analysis of the categorical data was
obtained by use of the chi-square test. The method of
univariate logistic regression assessed the association of
every potential predictor (independent variable) individually
with neuropathic characteristics. Independent variables in
the single models included age, sex, education level, depres-
sion, pain intensity, pain chronicity, disability, pain history
and length of hospital stay. After conducting univariate
analyses, the variables with a significant association to
neuropathic characteristics were fed into hierarchical mul-
tiple regression analyses (method: Enter). First, pain inten-
sity and pain chronicity were assessed regarding their
association with neuropathic characteristics, as some studies
have indicated these factors are correlated with neuropathic
pain (Margot-Duclot et al., 2009; Gerbershagen et al., 2010).
In a second step in the regression analyses, disability and
length of hospital stay were entered into the model, as it has
been shown that patients with neuropathic symptoms
report lower functionally and a greater use of health care
facilities (Freynhagen et al., 2006a; Gerbershagen et al.,
2010). Finally, a psychological variable (depression) was
entered into the model, as we wanted to investigate whether
the inclusion of a psychological variable increased the total
amount of explained variance in the dependent variable
(neuropathic characteristics) after controlling for the previ-
ously entered pain-related variables. This statistical strategy
allows determination of the increase in explained variance
by each block of variables entered. Variance inflation factors
(VIFs) were calculated for the independent variables in order
to test the assumption of collinearity (Myers, 1990). All of
the data were analysed by Statistical Package for the Social
Sciences software, version 19. The significance level was set
at p < 0.05.
3. Results
3.1 Study sample
Of the 500 patients, 100 patients had to be excluded
from the study: 15 patients because they had pain
history less than 6 months, 27 patients in whom
tumour was diagnosed and 58 patients who refused to
answer the questionnaires. Out of all 400 participants,
148 patients (37%) had a PDQ score  19 and were
considered to have chronic pain with predominantly
neuropathic characteristics (NP group). About 27% of
patients (n = 111) were assigned to the ‘unclear’ group
(UC; PDQ score: 13–18), and 141 patients (35.2%)
had a PDQ score  12 and thus were considered to
have chronic pain without any reliable neuropathic
characteristics (no–NP group).
The mean age of the patients was 57.8 years old
[standard deviation (SD) = 14.4], and the highest per-
centage of patients (28%) belonged to the age group
between 51 and 60 years old (Table 1). The majority of
patients were female (62.5%) and about 46% had
primary education (Table 1).
There was no significant difference between the
groups regarding mean age (F (2, 397) = 1.15;
p = 0.31, Table 1). Also, no significant differences
were found regarding age group (X2 = 14.3, d.f. = 12,
p = 0.27), sex (X2 = 1.24, d.f. = 2, p = 0.53) or employ-
ment status (X2 = 1.53, d.f. = 2, p = 0.46). However,
our data demonstrated significant differences between
groups regarding retirement due to normal age or
disability (X2 = 14.43, d.f. = 2, p = 0.000, Table 1).
3.2 Comparison of diagnostic groups
Fig. 1 shows the number of patients as well the PDQ
scores in each of the diagnostic groups. The different
diagnostic groups were examined regarding their PDQ
scores by ANOVA and post hoc tests. The patients diag-
nosed with ‘neuropathic pain’ showed the highest
PDQ scores (M = 17.79, SD = 6.38; F (5, 394) = 2.26;
p = 0.04, Fig. 1). The PDQ score of the ‘neuropathic
pain’ group was significantly different from ‘spinal
column pain’ (p = 0.01), ‘headache’ (p = 0.03) and
‘other pain’ (p = 0.03) groups. However, the PDQ
score of the ‘neuropathic pain’ group did not signifi-
cantly differ from that of the ‘musculoskeletal pain’ or
‘postsurgical pain’ groups (Fig. 1).
3.3 Comparison of pain DETECT-groups (NP, UC,
no-NP groups)
Results of ANOVA showed significant differences
between the groups regarding pain intensity (MNP =
6.9, SD = 1.6; MUC = 6.4, SD = 1.7; Mno-NP = 5.9,
SD = 1.7; F (2,385) = 13.3, p = 0.000) and depression
(MNP = 14.2, SD = 5.3; MUC = 12.5, SD = 7.3, Mno-NP =
9.1, SD = 4.8, F (2,307) = 22.68, p = 0.000). Post hoc
tests also revealed significant differences between NP
versus no-NP and UC versus no-NP groups for pain
intensity and depression (Table 2). In addition, there
were significant differences between groups in pain
chronicity score (MNP = 9.02, SD = 1.2; MUC = 8.6,
SD = 1.2; Mno-NP = 8.2, SD = 1.2, F (2,396) = 14.04,
p = 0.000) and disability (MNP = 43.2, SD = 13.8;
MUC = 38.2, SD = 14.3, Mno-NP = 33.2, SD = 13.9, F
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(2,349) = 14.91, p = 0.000). Accordingly, post hoc tests
demonstrated significant differences between each of
the analysed groups regarding pain chronicity and dis-
ability (Table 2). The length of hospital stay in the NP
group was also significantly different from the no-NP
group (MNP = 15.1, SD = 4.9; Mno-NP = 13.6, SD = 4.3; F
(2,385) = 3.1, p = 0.03, Table 2). No significant differ-
ences were found when comparing the NP and
UC (p = 0.45) or the UC and no-NP groups (p = 0.49).
No group differences were found regarding pain history
(MNP = 10.7, SD = 9.1; MUC = 10.6, SD = 10.2, Mno-
NP = 10, SD = 9.4, p = 0.8, Table 2).
3.4 Univariate logistic regression models
Univariate multinominal logistic regression with
no-NP as a reference group revealed that neither age
(p = 0.3), sex (p = 0.5), education level (p = 0.8) nor
pain history (p = 0.8) were significantly correlated
with neuropathic characteristics when analysed as
single predictors (Table 3). The variables pain chronic-
ity (8.3% of explained variance), pain intensity (8% of
explained variance), disability (9.6% of explained
variance) and length of hospital stay (2.8% of
explained variance) were significantly associated with
neuropathic characteristics. The depression scores
(PHQ score) were also significantly associated with
neuropathic characteristics and achieved the best
model fit, explaining 15 % of the variance (Table 3).
3.5 Multiple regression analyses
The collinearity statistics showed that tolerance levels
were between 0.7 and 0.9 and VIFs for all variables
were between 1.05 and 1.34, indicating that
multicollinearity was not present. Hierarchical mul-
tiple regression analyses were conducted in order to
examine the contributions of variable blocks entered
simultaneously to the prediction of neuropathic char-
acteristics. In the first step of the hierarchical regres-
sion analyses, pain chronicity and intensity were
assessed regarding their association with neuropathic
characteristics. These variables made significant
contributions to the explanation of variance in
‘neuropathic characteristics’, explaining 13% of the
variance. In the second step, disability and length of
hospital stay were included in the model. Disability
turned out to be a significant predictor in this model
(b = 0.17, p = 0.005), but length of hospital stay did
not. This model achieved a variance explanation of
2% more than the previous model (R2 = 15%)
[DR2 = 0.02, DF (2, 286) = 4.4, p = 0.01, Table 4].
Table 1 Patient description and analysis of group differences (chi-square, t-tests).
Variable
NP UC no-NP Total
F(df) / X2 (df)n = 148 n = 111 n = 141 n = 400
Age (Mean  standard deviation) 57.5  14.6 56.4  12.1 59.2  15.8 57.8  14.4 F (2/ 397) = 1.15a
Age groups, n (%)
<20 3 (2.0%) 0 4 (2.8%) 7 (1.8%)
21–30 3 (2.0%) 1 (0.9%) 3 (2.1%) 7 (1.8%)
31–40 9 (6.1%) 5 (4.5%) 8 (5.7%) 22 (5.5%)
41–50 33 (22.3%) 31 (27.9%) 25 (17.7%) 89 (22.3%) X2 (12) = 14.3a
51–60 41 (27.7%) 38 (34.2%) 33 (23.4%) 112 (28%)
61–70 27 (18.2%) 17 (15.3%) 26 (18.4%) 70 (17.5%)
>70 32 (21.6%) 19 (17.1%) 42 (29.8%) 93 (23.3%)
Sex, n (%)
Female 96 (64.9%) 71 (64%) 83 (58.9%) 250 (62.5%) X2 (2) = 1.24a
Education level, n (%)
None 1 (0.7%) 2 (1.8%) 3 (2.1%) 6 (1.5%)
Primary education 67 (45.6%) 56 (51.4%) 60 (42.9%) 183 (46.2%)
Secondary school 52 (35.4%) 26 (23.9%) 46 (32.9%) 124 (31.3%) X2 (8) = 7.11a
High school certificate 4 (2.7%) 7 (6.4%) 8 (5.7%) 19 (4.8%)
College or university degree 23 (15.6%) 18 (16.5%) 23 (16.4%) 64 (16.2%)
Employment status, (%)
Employed / unemployed 30.3% / 9% 20.8% / 6.2% 28.7% / 5.1% 79.8% / 20.3% X2 (2) = 1.53a
Retired due to: (normal age / disability) 21.5% / 15.3% 12.9% / 12.3% 31.9% / 6.1% 66.3% / 33.7% X2 (2) = 14.43***
NP, chronic pain with neuropathic characteristics (PDQ score  19); UC, uncertainty regarding neuropathy (PDQ score 13–18); no-NP, chronic pain
without any reliable neuropathic characteristics (PDQ score  12).
*** p < 0.001.
aNot significant.
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Finally, depression was entered into the model.
Depression also contributed to the prediction of
neuropathic characteristics in this model (b = 0.23,
p = 0.000). The inclusion of a psychological variable
led to a 5% increase in explained variance, for a total
explanation of variance of 20% [DR2 = 0.04, DF (1,
285) = 15.3, p = 0.000, Table 4]. Pain chronicity
(b = 0.16, p = 0.004) and pain intensity (b = 0.12,
p = 0.04) also remained as predictive factors in this
model, but the variable ‘disability’ did not maintain
its status as a predictive variable (p = 0.13) [F (7,
285) = 10.21, p = 0.000].
4. Discussion
The main objective of the study was to investigate
neuropathic characteristics of different pain diagnoses
using the PDQ to scale the level of neuropathic
symptoms.
Our findings demonstrated the presence of distinct
neuropathic characteristics (PDQ score  19) in 37%
of patients with different types of chronic pain, who
belonged to pain syndrome groups not only clinically
diagnosed as ‘neuropathic pain’, but also otherwise
diagnosed pain. This finding is in accordance with
some previous studies. Freynhagen et al. (2006b)
reported that 33.5% of chronic back pain patients
suffer from distinct neuropathic characteristics. Addi-
tionally, some previous studies on migraine (e.g.,
David and Biondi, 2006) and fibromyalgia (e.g.,
Koroschetz et al., 2011) indicated that neuropathic
features are also present in those pain diagnoses.
The validity of the PDQ score is supported by the fact
that the clinical group with diagnosed ‘neuropathic
pain’ scored the highest on the PDQ on average.
However, it has to be pointed out that the clinical
group diagnosed as ‘neuropathic pain’ demonstrated
an average PDQ score less than 19 (the cut-off point
for ‘distinct’ neuropathic characteristics). Moreover,
no significant differences were found regarding
the PDQ scores for the ‘neuropathic pain’,
‘musculoskeletal pain’ and ‘post traumatic or surgical
pain’ groups.
This could be due to the fact that, although the PDQ
was developed and validated on a sample of chronic
pain patients with various neuropathic or nociceptive
pain syndromes, it specifically targeted chronic low
back pain. Thus, it seems that this screening tool could
not be used to differentiate typical neuropathic entities

















Figure 1 Number of patients as well as PDQ scores regarding pain diag-
noses.
Note. PDQ score on pain DETECT questionnaire; other pain group
includes: facial pain (n = 1), ischaemic pain (n = 1), visceral pain (n = 2)
and somatic unclassifiable pain (n = 6); ns, not significant.
Table 2 Results of one-way analysis of variance (ANOVA) and post hoc Tukey’s test.
Variable NP (n = 148) UC (n = 111) no-NP (n = 141) F (d.f.) Tukey test (p < 0.05)
Mean pain intensity (NRS) 6.9  1.6 6.4  1.7 5.9  1.7 13.3 (2 / 385)*** (NP, UC) > no-NP
Pain Chronicity (MPSS score) 9.02  1.2 8.6  1.2 8.2  1.2 14.04 (2 / 396)*** NP > UC > no-NP
Disability (PDI) 43.2  13.8 38.2  14.3 33.2  13.9 14.91 (2 / 349)*** NP > UC > no-NP
Depression (PHQ) 14.2  5.3 12.5  7.3 9.1  4.8 22.68 (2 / 307)*** (NP, UC) > no-NP
Length of hospital days 15.1  4.9 14.3  4.4 13.6  4.3 3.11 (2 / 385)* NP > no-NP
Pain history (years) 10.7  9.1 10.6  10.2 10  9.4 2.6 (2 / 327)a –
NP, chronic pain with neuropathic characteristics (PDQ score  19); UC, uncertainty regarding neuropathy (PDQ score: 13–18); no-NP, chronic pain
without any reliable neuropathic characteristics (PDQ score  12); NRS, Numeric Rating Scale; MPSS, Mainz Pain Staging System; PHQ, Patient Health
Questionnaire; PDI, Pain Disability Index; *** p < 0.001; * p < 0.05; aNot significant.
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(e.g., Postherpetic neuralgia, Polyneuropathy) from
some other types of chronic pain with distinct
neuropathic characteristics (e.g., fibromyalgia).
A further possible limitation regarding our interpre-
tation also has to be taken into account. A high
percentage of fibromyalgia patients (60%, PDQ
scorefibromyalgia = 17.70) in the musculoskeletal pain cat-
egory in our sample may be responsible for the high
PDQ score in the musculoskeletal pain category.
Maletic and Raison (2009) suggested that neuropathic
pain and fibromyalgia have similar phenomenological
manifestations and may be variations of the same
condition. Koroschetz et al. (2011) also reported that
fibromyalgia and diabetic neuropathy patients experi-
ence very similar sensory phenomena. Moreover, prior
studies have emphasized that surgery can be an impor-
tant cause of neuropathic pain (Kehlet et al., 2006;
Shaladi et al., 2009) and it has been assumed that the
Table 3 Single variable models: odds ratio, 95% confidence intervals, significance and nagelkerke.
Variables UC NP Nagelkerke
Single variable models
Age (years) 0.98 (0.97–1.00)a 0.99 (0.97–1.00)a 0.007
Sex 0.80 (0.48–1.34)a 0.77 (0.48–1.24)a 0.003
Education level 0.011
None 0.85 (0.12–5.6)a 0.35 (0.03–3.44)a
Primary or secondary education 0.98 (0.50–1.95)a 1.12 (0.59–2.11)a
High school certificate 1.11 (0.34–3.66)a 0.50 (0.13–1.89)a
Depression (PHQ score) 1.13 (1.07–1.20)*** 1.19 (1.12–1.26)*** 0.15
Pain chronicity (MPSS score) 1.29 (1.05–1.59)* 1.67 (1.36–2.04)*** 0.083
Pain intensity (NRS score) 1.19 (1.03–1.39)* 1.43 (1.24–1.67)*** 0.080
Disability (PDI score) 1.02 (1.00–1.04)* 1.04 (1.03–1.06)*** 0.096
length of hospital days 1.03 (0.97–1.09)* 1.06 (1.01–1.12)* 0.028
Pain history 1.00 (0.97–1.03)a 1.00 (0.98–1.03)a 0.001
Reference group in regression analysis: no-NP group, non-neuropathic pain group; UC, uncertainty regarding neuropathy; NP, neuropathic pain group;
Sex (coding: 0 = male 1 = female); Education level: (coding: none = 0, Primary or secondary education = 1, High school certificate = 2, College or
university degree = reference category); PHQ, Patient Health Questionnaire; MPSS, Mainz Pain Staging System; NRS, Numeric Rating Scale; PDI, Pain
Disability Index.
***p < 0.001; **p < 0.01; *p < 0.05.
aNot significant.
Table 4 Neuropathic pain score: hierarchical regression analyses with depression and various pain-related variables as predictors.
Regression model
Criterion Predictors R2 B SEB b P
Model 1 0.131
Pain chronicity (MPSS) 1.25 0.31 0.22 0.000***
Pain intensity (NRS) 0.83 0.22 0.20 0.000***
Model 2
Pain chronicity (MPSS) 0.158 1.12 0.31 0.20 0.000***
Pain intensity (NRS) 0.56 0.24 0.13 0.02*
Disability (PDI) 0.08 0.02 0.17 0.005**
Length of hospital stay 0.05 0.08 0.03 0.49a
Model 3 0.201
Pain chronicity (MPSS) 0.90 0.31 0.16 0.004**
Pain intensity (NRS) 0.48 0.23 0.12 0.04*
Disability (PDI) 0.04 0.03 0.09 0.13a
Length of hospital stay -0.01 0.08 -0.007 0.89a
Depression (PHQ) 0.29 0.07 0.23 0.000***
Variables in the equation: Depression on Patient Health Questionnaire (PHQ), pain chronicity on Mainz Pain Staging System (MPSS), pain intensity on
11-point Numeric Rating Scale (NRS) and disability on Pain Disability Index (PDI) were measured. Higher ratings on all of these variables correspond to a
higher level of severity.
***p < 0.001; **p < 0.01; *p < 0.05.
aNot significant.
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frequency of neuropathic pain following surgical
procedures amounts to approximately 20% of admit-
ted patients (Shaladi et al., 2009). These findings
seem to suggest similarities in symptomatology of
‘neuropathic pain’, ‘musculoskeletal pain’ and ‘post
traumatic or surgical pain’, which would be reflected in
parallel responses on symptom-based questionnaires.
However, further research is necessary in this field.
In sum, our findings lend support to the notion that
any type of chronic pain may have neuropathic char-
acteristics. However, it seems that this screening tool
could not separate typical neuropathic entities from
some other pain syndromes with distinct neuropathic
features.
In contrast to Daniel et al. (2008), who found that
patients with neuropathic pain and patients with non-
neuropathic low back pain were similar in their
reports of pain intensity, dysfunctional cognition and
physical function, the present study found significant
differences between the NP, UC and no-NP groups in
various pain-related variables.
Our findings demonstrated a higher level of pain
intensity, pain-related disability and depressive symp-
toms in the NP group, consistent with some earlier
studies (e.g., Freynhagen et al., 2006a; Attal et al.,
2011; Beith et al., 2011). To explain these findings,
Hansson et al. (2001) suggested that patients with
neuropathic pain, in addition to the pain itself, expe-
rience various types of aversive or unfamiliar feelings
like paresthesias and burning sensations. These differ-
ent qualities of sensory experiences integrate into a
global feeling of intense discomfort and painfulness. It
can be assumed that these particular features of
neuropathic pain have a negative impact on the
general quality of life.
Additionally, although patients in the NP group did
not report a significantly longer history of pain, a
higher level of pain chronicity based on MPSS was
found in this group. This finding replicates previous
research by Gerbershagen et al. (2010). Consequently,
the greater use of health care facilities and drugs
among patients in the NP group (MPSS, axes 3, 4;
Mehra et al., 2012), in line with a higher severity of
pain and potentially inappropriate treatment of
neuropathic pain may be responsible for a high level
of chronicity in these patients, including long hospital
stays and high levels of functional and affective
disability.
The method of regression chosen to analyse the data
allowed deeper insight into the structure of the data
and validates the integrity of the reported results.
In line with the results of ANOVA and post hoc tests
that characterized the neuropathic dimension of
pain by high levels of pain intensity, pain chronicity
and depression, regression analyses also reflected
the same results (Margot-Duclot et al., 2009;
Gerbershagen et al., 2010; Boogaard et al., 2011). As
expected, the inclusion of a psychological variable
(depression) in a multiple regression analysis signifi-
cantly increased the total amount of variance
explained by pain variables. Maletic and Raison
(2009) proposed that major depression disorder
(MDD) and neuropathic pain are associated, as they
both have a common feature, i.e., neuroplastic
change. They further argued that the recurrent and
progressive nature of MDD is often ascribed to ‘kin-
dling’, which reflects neuroplastic changes like central
sensitization.
Also, the separate analyses of disability and length
of hospital stay confirmed their power to predict
neuropathic characteristics. However, these variables
lost their predictive power in a common model, indi-
cating that these variables shared some information
regarding the prediction of neuropathic characteristics
with other variables. Still, it does not seem justified to
regard the multiple regression analysis as the final
word regarding the associations of different variables
to the criterion, and thus further research is necessary.
Altogether, on the basis of our results, chronic
pain with neuropathic characteristics is characterized
by a high level of pain intensity and chronicity as
well negative affectivity and functional disability. This
should have implications for the symptom-based
therapeutic management of pain with distinct
neuropathic features.
5. Limitations
Some limitations regarding our general conclusion
might relate to the applied instrument. Although the
PDQ was validated on chronic pain patients with
typical neuropathic or nociceptive entities and it has
been applied in several previous studies on different
types of chronic pain (e.g., Gerbershagen et al., 2010;
Koroschetz et al., 2011), this questionnaire specifically
targets low back pain. Nevertheless, our data assessing
different pain syndromes are consistent with recent
studies using other screening tools (e.g., Attal et al.,
2011). However, the questionnaire so far has not been
validated regarding headache. Furthermore, compar-
ing patients based only on the self-report questionnaire
and not on clinical examination might endanger our
findings. Despite this limitation, our findings are con-
sistent with previous research on typical neuropathic
pain (e.g., Gustorff et al., 2008; Huge et al., 2011).
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Another limitation of the study is that we included a
sample of patients from a single clinic for our study and
this selection bias may affect the results of the study.
6. Conclusion
By using the pain DETECT assessment tool, the
present study finds some evidence to question the
categorical separation of so-called nociceptive and
neuropathic pain on the basis of their pathological
mechanisms. Although our findings are based on a
symptom-oriented screening tool and not on clinical
diagnostic data, it instigates further research examin-
ing therapeutic strategies depending on the syndrome
quality, not on the supposed cause of pain. It can
further be discussed whether treatment should espe-
cially target important symptoms determining the syn-
drome, like negative affectivity and disability, as well
as the severity of pain. This would mean that pain
characterized by a high neuropathic score should be
aimed primary at reduction in pain severity, but also at
improvements in the daily functions of the patient and
an induction of positive affect by a multidisciplinary
treatment. However, these conclusions can only be
speculative at the moment.
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Appendix S1.  Sub-classification of main pain syndrome of sample according to the Multiaxial 
Pain Classification System- Somatic Dimension (MASK-S, Hildebrandt et al., 1992; Klinger 





─ Tension-type headache 
─ Cluster headache syndrome 
─ Drug-induced headache 
─ Headache attributed to disorders of facial or cranial structures 
─ Headache attributed to cranial or cervical vascular disorders 
─ Other specified headache syndromes 
 
2. Non-neuropathic facial pain 
 
─ Atypical facial pain 
─ Facial pain attributed to other disorders (e.g., disorder of sinuses, teeth, etc) 
 
3. Ischemic or vascular pain 
 
─ Pain attributed to arterial Insufficiency in the limbs 
─ Pain attributed to vasodilating functional disease of the limbs 
─ Other vascular disorders of the upper and lower limbs 
 
4. spinal column pain 
 
─ Cervical spinal or radicular pain syndromes 
─ Thoracic spinal or radicular pain syndromes 
─ Lumbar spinal or radicular pain syndromes 
─ Sacral spinal or radicular pain syndromes 
─ Coccygeal pain syndromes 
─ Diffuse spinal pain 
5. Musculoskeletal pain 
 
─ Arthropathies (e.g., inflammatory polyarthropathies, arthrosis and other joint disorders) 
─ Myalgia 




─ Other disorders of the musculoskeletal system and connective tissue 
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6. Neuropathic pain 
 
─ Neuralgies (e.g., trigeminal neuralgia, postherpetic neuralgia, other specified neuralgies) 
─ Polyneuropathies (diabetic polyneuropathy, inflammatory polyneuropathy, Polyneuropathy 
due to toxic agents, other specified polyneuropathies) 
─ Mononeuropathies (carpal tunnel syndrome, diabetic mononeuropathy, other specified 
mononeuropathies) 
─ Complex regional pain syndrome (CRPS) 
─ Phantom and stump pain 
─ Central nervous system disease (e.g., multiple sclerosis, thalamus infarction, other specified 
central nervous system disease) 
 
7. Visceral pain 
 
─ Chest pain 
─ Abdominal pain 
─ Chronic pelvic pain syndromes 
─ Diseases of the bladder, uterus, ovaries, testis, and prostate 
─ Pain perceived in the rectum, perineum, and external genitalia 
 
8. Post traumatic or surgical pain 
 
9. Pain disorders related to psychological factors 
 
 




2. Original article 2 
Shaygan, M., Böger, A., Kröner-Herwig, B. (accepted). Neuropathic sensory symptoms: 
Association with pain and psychological factors. Neuropsychiatric Disease and Treatment. 
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Background: A large number of population-based studies of chronic pain considered neuropathic 
sensory symptoms to be associated with a high level of pain intensity and negative affectivity. The 
present study examines the question of whether this association previously found in non-selected 
samples of chronic pain patients can also be found in chronic pain patients with underlying pathology of 
neuropathic sensory symptoms. 
Methods: Neuropathic sensory symptoms in 306 patients with chronic pain diagnosed as typical 
neuropathic pain, radiculopathy, fibromyalgia or nociceptive back pain were assessed using the Pain 
DETECT Questionnaire. Two separate cluster analyses were performed to identify subgroups of patients 
with different levels of self-reported neuropathic sensory symptoms and furthermore to identify subgroups 
of patients with distinct patterns of neuropathic sensory symptoms (adjusted for individual response bias 
regarding specific symptoms). 
Results: ANOVA results in typical neuropathic pain, radiculopathy and fibromyalgia showed no significant 
differences between the 3 levels of neuropathic sensory symptoms regarding pain intensity, pain 
chronicity, pain catastrophizing, pain acceptance and depressive symptoms. However, in nociceptive 
back pain patients, significant differences were found for all variables except pain chronicity. When 
controlling for the response bias of patients in ratings of symptoms, none of the patterns of neuropathic 
sensory symptoms were associated with pain and psychological factors. 
Conclusions: Neuropathic sensory symptoms are not closely associated with higher levels of pain 
intensity and cognitive-emotional evaluations in chronic pain patients with underlying pathology of 
neuropathic sensory symptoms. The findings are discussed in term of differential response bias in 
patients with vs. without verified neuropathic sensory symptoms by clinical examination, medical tests or 
underlying pathology of disease. Our results lend support to the importance of using adjusted scores 
thereby eliminating the response bias when investigating self-reported neuropathic symptoms by patients. 
Keywords: Self-reported neuropathic sensory symptoms, pain-related features, psychological factors, 
response bias  





Neuropathic pain is defined as ‘pain caused by a lesion or disease affecting the somatosensory 
system’
1
 manifested by sensory signs and symptoms such as hyperalgesia, burning and prickling 
sensations. Boureau et al
2
, stated that verbal descriptors of experienced sensory symptoms reliably 
distinguish neuropathic pain from other types of pain. Several studies, however, found similar self-
reported sensory symptoms in otherwise diagnosed pain such as fibromyalgia
3
. 
A large number of population-based studies of chronic pain reported a high level of pain intensity as 
well anxiety and depressive symptoms in respondents who scored high on neuropathic sensory 
symptoms assessed by self-report
4-7
. These studies concluded that the neuropathic character of pain is 
denoted by a high level of intensity as well as negative affectivity. However, some clinical studies did not 
support these findings when comparing medically diagnosed neuropathic and non-neuropathic pain
8-10
. 
Consequently, two questions were raised: First, do neuropathic sensory symptoms assessed by 
screening tools reliably distinguish neuropathic pain from non-neuropathic types of pain? The present 
study assessed self-reported neuropathic sensory symptoms in patients with “typical neuropathic pain” 
(TNP), radiculopathy (RAD), fibromyalgia (FM) and nociceptive back pain (nBP). We expected that these 
symptoms would distinguish TNP not from RAD and FM but from nBP. RAD is caused by compression or 
lesion of a dorsal root or its ganglion and considered as a syndrome with both nociceptive and 
neuropathic components of pain (mixed pain syndrome
11-13
). Although in the majority of FM patients, no 
nerve lesions can be demonstrated, the presence of neuropathic sensory symptoms (eg, allodynia, 
hyperalgesia) in these patients can be explained in terms of pathogenic mechanisms such as impaired 
small fiber function and a dysfunction of endogenous systems modulating afferent activity
14-16
. In a more 
recent study, Uceyler et al
14
, suggested a neuropathic nature of pain in FM syndrome. However, the 
classification of FM as neuropathic pain is a subject of controversy and debate among researchers
1,17
. 
A further question was whether the association between a high score of self-reported neuropathic 
sensory symptoms with a high level of pain intensity and negative affectivity previously found in non-
selected samples of chronic pain patients can also be found in chronic pain patients with underlying 
pathology of neuropathic sensory symptoms such as TNP, RAD and also FM.  




Symptom reports are well known to be influenced by a general negative response tendency, revealed 
by a dominance of responses at the negative pole of a rating scale which is based on a person’s 
disposition to disclose and report negative aspects of oneself, including both emotional and physical 
symptoms. In this context, a general negative self-appraisal seems to play an important role. Such biases 
may inflate correlations among symptoms
18
. However, later studies suggested a considerable variation in 
how strongly different symptoms are influenced by this response bias. For example, response bias has 
been suggested to more strongly relate with the report of symptoms without any identified pathology than 
with symptoms that can be verified by clinical examination or medical tests
19-21
.  
In conclusion, it is argued that not only does the character of pain determine the symptom report, but 
also an individual tendency to select specific response categories, in this case preferring the endpoints of 
a response scale independent of the item content. This could have determined the positive correlation 
between self-reported neuropathic sensory symptoms with pain intensity and negative affectivity found in 
large population-based studies. This association should be examined in patients with an underlying 
pathology of neuropathic sensory symptoms. 
In the present study, we wanted to analyse the relation between the level of neuropathic sensory 
symptoms with other pain related parameters like intensity and chronicity as well psychological factors 
(depression, catastrophizing, pain acceptance) in four mentioned diagnostic groups, ie, TNP, RAD, FM 
and nBP. Cluster analysis was used to classify patients of these diagnostic groups based on self-reported 
intensity of neuropathic sensory symptoms (clustering 1). We hypothesised that only nBP patients who 
scored high on neuropathic sensory symptoms would report a high level of pain-related features and also 
psychological factors driven by the previously explained response bias. In all other diagnostic groups, 
significant associations were not expected. 
In order to control for the response bias, a second clustering approach (clustering 2) based on 
adjusted scores of neuropathic sensory symptoms using individual means was performed. This enabled 
us to subgroup the patients of the different diagnostic groups based on their distinct patterns of 
neuropathic sensory symptoms after having eliminated the individual response bias regarding the 
symptoms. Studies concerning the association of different patterns of neuropathic sensory symptoms with 




different parameters of pain and psychological factors are rare. A recent symptom-based study on chronic 
low back pain demonstrated no association between distinct patterns of neuropathic sensory symptoms 
with depression and anxiety
22
. We wanted to find out whether the different diagnostic groups in our study 
are characterised by specific patterns of neuropathic sensory symptoms (after elimination of the general 
response bias). We expected that these symptom patterns should be represented differently in the 
diagnostic groups. However, since the general response bias was eliminated, none of the symptom 
patterns should be associated with higher levels of pain related parameters or psychological factors. 
Methods 
This cross-sectional study was conducted in a multidisciplinary tertiary care centre, comprising 
experts in pain medicine, psychology and neighbouring professions. In-patients presenting with chronic 
pain, diagnosed by anesthesiologists/ neurologists, were asked to complete various questionnaires, after 
having signed informed consent regarding their participation in the study. Ethical approval was obtained 
from the Ethics Committee of the Georg-Elias-Mueller Institute of Psychology.  
Sample selection 
From April 2012 to February 2013, 344 patients suffering from a chronic pain condition were referred 
to the pain treatment centre. Chronic pain conditions included TNP, RAD, FM or nBP assessed by the 
pain specialists who determined the pain diagnoses based on history, clinical bedside examinations and 
whatever diagnostic methods were considered appropriate (eg, electrophysiological evaluation, imaging 
techniques, etc.). A total of 78 patients with one of the following neurological syndromes were included 
into the study: postherpetic neuralgia (PHN, which was confirmed if patients had persistent pain in an 
area previously affected by acute herpes zoster rash), complex regional pain syndrome type II (CRPS II, 
according to clinical criteria)
23
, central neuropathic pain (defined as pain caused by a demonstrable lesion 
in the central nervous system in an area anatomically attributable to the lesion), polyneuropathy (PNP, 
according to clinical criteria)
24
  and trigeminal neuralgia (according to International Headache 
Classification criteria 2003). Patients with chronic low back pain were divided in two groups: with (RAD) or 




without (nBP) typical dermatomal pain (radiating beyond the knee, pain evoked by stretching of the 
femoral nerve) as well as clinical signs of nerve root involvement, including sensory or motor deficits in 
the leg and a decrease or loss of tendon reflexes. Moreover, available results of spinal imaging and 
further investigations such as electromyography were also taken into account. Fibromyalgia was 
diagnosed on the basis of the American College of Rheumatology criteria
26
 (ACR). Of the 344 patients, 
306 were considered for inclusion in the study. Criteria for inclusion were: age above 18 years and having 
a chronic pain condition according to ICD-10 criteria (F45.41 or R52.1-2, International Statistical 
Classification of Diseases and Related Health Problems, 2012)
27
. The following exclusion criteria were 
applied: a pain history less than 6 months, presence of a malignant disease, severe medical or 
psychiatric illness interfering with the pain assessment, another painful disorder or neurological disease 
that might have interfered with the pain assessment, and inability to comprehend the German language. 
Data assessment 
In addition to standard demographic inquiry, the following questionnaires were applied: 
Neuropathic sensory symptoms were assessed by the Pain DETECT Questionnaire (PDQ
4
). The 
PDQ is a self-report questionnaire including nine items asking about the intensity and quality of pain. The 
questions address the presence of seven sensory symptoms rated on a 0–5 rating scale (never to very 
strong): 1. burning pain, 2. paresthesias, 3. mechanical allodynia, 4. spontaneous pain attacks, 5. thermal 
hyperalgesia, 6. numbness, 7. pressure hyperalgesia. The PDQ also comprises two questions regarding 
the course of pain and radiation pain. The scale was validated in a sample of patients with either 
neuropathic pain, including post-herpetic neuralgia, polyneuropathy, nerve trauma and low back pain 
(LBP where the source of pain is in lumbar vertebrae, sacrum and/or coccyx) or nociceptive pain 
including visceral pain, osteoarthritis, inflammatory arthropathies and non-neuropathic LBP. The 
instrument indicated sensitivity as well specificity of 84% when identifying patients with medically 
diagnosed neuropathic pain. The questionnaire demonstrated adequate internal consistency (Cronbach’s 
alpha= 0.83
4
).   




      The average pain intensity was assessed by an 11-point numeric rating scale
28
 (NRS; 0 (no pain) to 
10 (worst imaginable pain)). 
Pain chronicity was assessed by the Mainz Pain Staging System
29
 (MPSS). The MPSS defines three 
stages of pain chronicity based on ten questions (in terms of 4 axes). Patients were requested to describe 
the occurrence of pain, pain duration and changes in pain intensity (axis 1, temporal dimension); pain 
distribution (axis 2, spatial dimension); drug use and number of previous drug withdrawal (axis 3, drug 
taking behaviour); change of personal physician, pain related hospitalizations, pain related operations and 
pain related rehabilitation (axis 4, utilization of the health care system). Patients were assisted by a 
physician to complete the questions. The sum of the 4 axes varies in the range of 4–12. The instrument 
was validated in a study by Pfingsten et al with 542 patients with different diagnoses
30
.  
Depressive symptoms were assessed by the German short version
31
 of the Center for 
Epidemiological Studies Depression Scale
32
 (CES-D). It is a 15-item self-report scale from 0 (rarely) to 3 
(most of the time) designed to measure depressive symptoms during the past seven days. Validity and 
reliability (Cronbach’s alpha= 0.91) were good
31
. 
 Catastrophizing cognitions concerning pain were measured with the German version of the Pain 
Catastrophizing Scale
33
 (PCS, subscale “helplessness”). The subscale “helplessness” describes the 
feeling of inability to cope with the pain. It consists of 6 items answered on a 5-point scale ranging from 0 
(not at all) to 4 (all the time). This subscale showed good internal consistency (Cronbach alpha= 0.89) as 
well convergent validity
33
.    
 Pain acceptance was measured by 10 items from the German version of the Chronic Pain 
Acceptance Questionnaire (items 1, 2, 6, 9, 11, 12, 13, 14, 15, 18; CPAQ-D)
34
. These items showed the 
highest correlation with the total score of the questionnaire
34
. Items were answered on a 7-point scale 
ranging from 0 (never) to 6 (always), with an internal consistency of α = 0.73.  
 
 





One-way analyses of variance (ANOVAs), post-hoc Tukey's tests and chi-square tests were 
conducted to explore differences between the four diagnostic groups regarding demographic and clinical 
variables.  
To distinguish subgroups of patients with different levels of self-reported neuropathic sensory 
symptoms across the 4 diagnostic groups (clustering 1), a hierarchical cluster analysis including the 
seven sensory symptoms taken from the Pain DETECT Questionnaire was performed. The commonly 
recommended hierarchical WARD-approach with a squared Euclidian distance measure was used
35
. 
Agglomeration coefficients were investigated to establish the optimal cluster solution. The point at which 
the percentage of change was largest between steps determines the most appropriate cluster solution
36
. 
A cut-off point for essential clusters was set at about 10% of evaluated cases. Multinominal regression 
analysis was conducted to examine associations between the levels of self-reported neuropathic sensory 
symptoms (clusters as predictors) with diagnostic groups (criterion). Furthermore, ANOVAs were 
performed to investigate differences between these clusters regarding pain related and psychological 
variables (separately for each diagnostic group as well as for total sample of patients as a comparison 
with non-selected samples of chronic pain).  
For the purpose of identifying relevant subgroups of patients with different patterns of neuropathic 
sensory symptoms, a further hierarchical cluster analysis (clustering 2) was conducted on the basis of 
adjusted scores using the individual mean of the seven sensory symptoms, i.e. the rating of each item by 
the patient was subtracted from the individual mean of all seven items rated by the same patient, thus 
eliminating the response bias of patients. This cluster analysis was followed by multiple discriminant 
analysis including the seven sensory symptoms as independent variables (criterion: clusters), to ensure 
the stability of the cluster solution
35
. ANOVAs and chi-square tests were performed to explore differences 
between the identified clusters regarding various pain and psychological variables as well regarding their 
frequency in each diagnostic group. All analyses were conducted by SPSS software, version 19. The 
significance level was set at p<0.05. 






Of the 344 patients, a total of 306 with TNP, RAD, FM or nBP fulfilled the inclusion criteria. Thirty 
eight patients had to be excluded from the study: 11 patients because they had a pain history of less than 
6 months, 16 patients in whom tumour or other medical or psychiatric illness interfering with the pain 
assessment was diagnosed (e.g., Alzheimer’s disease, Schizophrenia), 6 patients because of their 
inability to comprehend the German language and 5 patients who refused to participate. The mean age of 
the patients was 59.2 years (SD=13.2). ANOVA and post-hoc tests showed significant differences 
between TNP and FM patients regarding age (p=0.02), the latter being younger on average. The majority 
of patients were female (65%). Separate chi-square tests demonstrated a lower percentage of women in 
TNP compared to nBP (p=0.007) and FM (p=0.000, see Table 1). Also, results of the ANOVA and post-
hoc tests revealed significant differences between FM vs. nBP and FM vs. TNP regarding pain chronicity 
(p=0.000) and between FM vs. RAD and FM vs. TNP regarding depressive symptoms (p=0.006, see 
Table 1). The neuropathic character (assessed by the PDQ total score) of nBP was significantly lower 
than in all other diagnostic groups (p=0.02, see Table 1). No group differences were found regarding pain 
history (p=0.12), pain intensity (p=0.69), pain acceptance (p=0.07) or catastrophizing (p=0.09, see Table 
1). 
                                               - Please insert Table 1 –  
Cluster analysis 1: Subgroups of patients with different levels of self-
reported neuropathic sensory symptoms  
Based on the agglomeration coefficients for hierarchical cluster analysis, three distinct clusters 
emerged which were characterised by either a low (MLow=1.38, SD=0.69), moderate (MModerate=2.51, 
SD=0.50) or high (MHigh=3.36, SD=0.65) level of intensity of self-reported neuropathic sensory symptoms 
which differed significantly from one another (F (2,295)=267.72, p=0.000).  
 




Multinominal logistic regression analysis 
Multinominal logistic regression (criterion: diagnostic groups) with TNP as a reference group revealed 
that the levels of self-reported neuropathic sensory symptoms only contributed to distinguishing TNP from 
nBP and not from RAD and FM. The model explained about 19% of the total variance (Table 2). 
- Please insert Table 2 – 
Association of self-reported neuropathic sensory symptoms with pain 
and psychological variables in the four diagnostic groups 
Results of the ANOVA showed no significant differences between the three levels of neuropathic 
sensory symptoms regarding pain intensity, pain chronicity, pain catastrophizing, pain acceptance and 
depressive symptoms (all ps > 0.05) in TNP, RAD and FM (see Table 3 for more detail).  
However, in nBP patients, significant differences were found regarding all variables, except pain 
chronicity (see Table 3 for further details). Accordingly, post-hoc tests demonstrated significant 
differences between low vs. high level of neuropathic sensory symptoms for pain intensity and pain 
catastrophizing, between low vs. moderate and high level of neuropathic sensory symptoms for pain 
acceptance and between low and moderate vs. high level of neuropathic sensory symptoms for 
depressive symptoms.  
ANOVAs comparing all pain patients in the three levels of neuropathic sensory symptoms 
demonstrated significant differences regarding all variables, except with regard to pain catastrophizing 
(for details see Table 3). Post-hoc tests also revealed significant differences between low and moderate 
vs. high level of neuropathic sensory symptoms for pain intensity, pain chronicity and depressive 
symptoms and between low vs. high level of neuropathic sensory symptoms for pain acceptance.  
                                            - Please insert Table 3 –  
 
 




Cluster analysis 2: Subgroups of patients with distinct patterns of neuropathic 
sensory symptoms  
The cluster analysis based on adjusted scores of the seven sensory symptoms led to a four-cluster 
solution with distinct patterns of symptoms (Figure 1). Each of the 4 symptom patterns was present in 
every diagnostic group differing only by relative frequency. Cluster 1 was characterised by a high intensity 
of prickling sensations (Madj= 0.98), pain attacks (Madj= 0.98) and numbness (Madj= 0.62) compared to the 
other sensory symptoms. This pattern of symptoms occurred nearly two times more frequently in TNP 
(26%) than in FM (15%), in nBP (13.3% ) and in RAD (12.9%; X
2
=6.33, df=3, p=0.09, see Figure 1). 
Patients who had been classified into cluster 2 reported particularly high levels of pain attacks (Madj= 
1.56) and pressure hyperalgesia (Madj= 0.97). All other symptoms were close to the mean, except burning 
pain which was less severe. In patients with nBP (44.9%), FM (38.3%) and RAD (28.6%), this symptom 
pattern was more frequent than in TNP patients (14.3%; X
2
=23.87, df=3, p=0.000, see Figure 1). Cluster 
3 was characterised by an overall “flat profile”, i.e. no item deviated much from the individual mean (see 
Figure 1). This pattern of symptoms evenly distributed over all four diagnostic groups (X
2
=6.06, df=3, 
p=0.10, see Figure 1). The dominant symptom of cluster 4 was a severe burning pain (Madj= 2.05). Pain 
attacks (Madj= 0.98) and thermal pain (Madj= 0.67) were also above the individual mean. All other 
symptoms were below average. This symptom pattern prevailed in TNP (19.5%), in RAD (15.7%) and in 
FM (13.3%, see Figure 1).  
A discriminant analysis with the seven neuropathic sensory symptoms as independent variables 
(criterion: the 4 patterns of neuropathic sensory symptoms) led to 3 significant discriminating functions 
(p=0.000 for each function) with Wilks’ lambda of 0.16, 0.36 and 0.63 and eigenvalues of 1.24, 0.75 and 
0.57. Eighty-eight percent of the patients were classified correctly. Burning pain (β=0.99), thermal 
hyperalgesia (β=0.91) and pain attacks (β=0.84) were the best predictors for the clusters (symptom 
patterns). But also, prickling sensations (β=0.56), pressure hyperalgesia (β=0.55), numbness (β=0.48) 
and allodynia (β=0.40) contributed significantly to the discrimination of the four clusters.  




The results of the ANOVAs showed no significant differences regarding pain intensity (p=0.95), pain 
chronicity (p=0.11), pain catastrophizing (p=0.87), pain acceptance (p=0.46) and depressive symptoms 
(p=0.78) when comparing the four clusters based on adjusted scores. 
                                             - Please insert Figure 1 –  
Discussion  
The present study demonstrates that neuropathic sensory symptoms do not contribute to the degree 
of pain intensity, pain chronicity and negative affectivity in a clinical sample of patients with underlying 
pathology of neuropathic sensory symptoms, ie, TNP, RAD and FM. Our findings also highlight the fact 
that high ratings of self-reported neuropathic sensory symptoms are not necessarily associated with 
major neuropathic characteristics of pain but are also related to a negative response tendency in patients 
without any identifiable underlying pathology of neuropathic sensory symptoms, ie, nBP. These results 
demonstrate the importance of taking advantage of response bias-adjusted scores when investigating 
self-reported neuropathic symptoms by patients.  
The assumption that neuropathic sensory symptoms would differentiate TNP from nBP was confirmed 
by the results of regression analysis (Table 2). Patients medically diagnosed with nBP also revealed the 
lowest neuropathic score assessed by the Pain DETECT Questionnaire differing significantly from all 
other diagnostic groups (TNP, RAD, FM) which are supposed to present pain with underlying pathology of 
neuropathic sensory symptoms (Table 1). Neuropathic sensory symptoms, however, did not distinguish 
TNP from FM. Although in the majority of FM patients no nerve lesion can be detected
37
, numerous 
studies demonstrated similarities between neuropathic pain patients and FM patients with regard to the 
experience of sensory symptoms
3
. Vierck suggested that changes in the milieu of muscles and other 
deep somatic structures in FM might lead to a similar state of hyperactivity in nociceptive neurons as is 
observed after nerve damage
37
. Moreover, Staud, using functional MRI, provided strong support for 
neuroplastic CNS changes in FM
38
.  However, it must be stressed that the classification of FM as a 




As hypothesised, the three levels of self-reported neuropathic sensory symptoms in chronic pain 
patients with underlying pathology of neuropathic sensory symptoms did not differ in pain intensity and 




chronicity, depression, pain acceptance and catastrophizing. Thus, neuropathic sensory symptoms do not 
contribute per se to the character of pain-related features and cognitive-emotional processes. This 
interpretation finds support in some clinical studies
8-10
 as well as our own findings (Table 1) indicating no 
significant differences between medically diagnosed neuropathic and non-neuropathic pain regarding 
pain intensity, pain chronicity and psychological factors. Other possible explanations for this result may be 
that negative emotions and maladaptive appraisals do not play an important role in the report of sensory 
descriptors of pain such as neuropathic sensory symptoms. In accordance with this interpretation, 
Sullivan found that pain catastrophizing in neuropathic pain patients was not associated with the sensory 
subscale of the McGill Pain Questionnaire but only with the affective aspects
39
. They suggested that the 
mechanism of pain catastrophizing is specifically related to the affective dimension of pain. Functional 
imaging studies with FM also demonstrated that neither a high level of pain catastrophizing
40
 nor the 
presence of a clinically diagnosed major depression
41
 were associated with the sensory aspects of pain 
processing.  
In contrast to this finding, in patients with nBP an association between high levels of neuropathic 
sensory symptoms with high levels of pain intensity, depression, pain catastrophizing and with less 
acceptance of pain was observed suggesting a general negative response tendency among patients with 
nBP who scored high on neuropathic sensory symptoms without any identifiable underlying 
neuropathology. Ambiguity about the origin and significance of neuropathic sensory symptoms among 
patients with nBP may explain the biased response tendency regarding these symptoms particularly 
among those nBP patients with negative affect and self-appraisals. According to Social Comparison 
Theory
42
 and Temporal Comparison Theory
43,44
, individuals need comparison standards to evaluate their 
opinions, skills, social status, as well as their physical state. Petersen et al, proposed the comparison 
standards as a predictor of symptom presentations and contended that in evaluating a bodily state, 
individuals have to use reference standards, such as the personal experience of symptoms in the past, or 
beliefs about the perception of sensations by relevant others, such as patients or healthy individuals
45
. It 
can be, therefore argued that those nBP patients with negative affect and self-appraisals were most likely 
influenced by a biased response tendency regarding neuropathic sensory symptoms. The finding that the 




three levels of neuropathic sensory symptoms in nBP did not differentiate pain chronicity which was not 
obtained by self-report may provide additional evidence for the argument above.  
Altogether, our findings suggest that a high level of neuropathic sensory symptoms in patients with 
underlying pathology of neuropathic sensory symptoms does not automatically result in a high intensity of 
pain related characteristics and psychological dysfunctional features but that the group of patients (nBP) 
with a general negative response tendency determine such an association which was partly found in 
other studies, especially when mixed patients were analysed. This spurious positive association can also 
be seen in our total sample of patients as the consequence of the discussed effect. Further studies 
therefore should control for this effect of differential response bias in their samples.  
With the second clustering approach, response bias-adjusted scores were created. This enabled us 
to characterise different subgroups of patients with common patterns of neuropathic sensory symptoms. 
Consistent with earlier studies
9
, none of the symptom patterns was exclusively seen in the groups with 
diagnosed neuropathic or nociceptive pain. Nevertheless, the distributions of symptom patterns differed 
between different diagnostic groups. For example, symptom pattern 4 occurred only in 2% of the patients 
with nBP whereas nearly half of the nBP patients demonstrated the symptom pattern characterised by a 
high level of pain attacks and pressure hyperalgesia (cluster 2). In any case, we found that neither the 
symptom patterns frequently occurring in neuropathic pain nor symptom patterns frequently occurring in 
nociceptive back pain were associated with a higher level of pain-related and psychological factors. This 
finding gives reason to further question a genuine association of neuropathic sensory symptoms with high 
levels of pain and psychological factors in patients with underlying pathology of neuropathic sensory 
symptoms.  At the same time, it highlights the adequacy of our strategy for analysis. 
Intriguingly, about 40% of the chronic pain patients showed a “flat profile” of neuropathic sensory 
symptoms. The “flat profile” indicates that the patient responded in a similar way to all items of the Pain 
DETECT Questionnaire. This pattern was demonstrated by a similar percentage of subgroups of patients 
from the four diagnostic groups, a finding that has been reported before
46
. Possibly, a psychological 
phenomenon, ie, the tendency to adhere to a similar rating style regardless of item content, is responsible 
for this observation. For a more accurate interpretation, we compared patients demonstrating a “flat 




profile” with different levels of neuropathic sensory symptoms (in clustering 1). Interestingly, among nBP 
patients who scored “high” (in clustering 1) as well as “flat” on neuropathic sensory symptoms, we found a 
higher level of depressive symptoms (p=0.004), pain catastrophizing (p=0.04) as well as less acceptance 
of pain (p=0.04). Consistent with this finding, Cohen et al proposed that negative emotions may not only 
result in a negative response bias as discussed before but also lead to an undifferentiated interpretation 
of symptoms
47
. Such differences were not found regarding TNP, RAD and FM with a “flat “and also “high” 
pattern of neuropathic sensory symptoms. This result can be interpreted that a “flat & high” pattern of 
neuropathic sensory symptoms is not necessarily based on a response bias particularly in the case of 
symptoms supported by underlying pathology.  
Before considering the implications of our findings, several limitations of this study have to be 
acknowledged. The sample size was relatively small, and thus the reliability of the findings has to be 
questioned until other studies can replicate them. An additional limitation relates to the applied 
instrument, since the PDQ has not been validated regarding FM.  Furthermore, our sample of patients 
was recruited from a single clinic and this selection might have affected the results.  
In summary, our data seems to highlight the conclusion that neuropathic sensory symptoms do not 
contribute to the degree of pain and psychological dysfunctional features in a clinical sample of patients 
with underlying pathology of neuropathic sensory symptoms. Moreover, the present study corroborates 
previous findings that response bias may more strongly relate with the report of symptoms without any 
identified pathology as well as symptoms which were not experienced by patients in the past than with 
symptoms that can be verified by clinical examination or medical tests. These findings should have 
implications for symptom-based studies of neuropathic pain to include a relevant sample of patients when 
investigating the association of these symptoms with other indicators of health status. The results also 
highlight the importance of using adjusted scores to eliminate the response bias when investigating self-
reported symptoms by patients.  
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Table 1. Demographic and clinical characteristics of patients (Results of one-way analysis of variance 
(ANOVA), post-hoc Tukey’s tests and chi-square test) 
 
Note. TNP = typical neuropathic pain; RAD = radiculopathy; FM = fibromyalgia; nBP = nociceptive back pain; NRS, Numeric Rating 
Scale; MPSS, Mainz Pain Staging System; PDQ, Pain DETECT Questionnaire; PCS-H, Pain Catastrophizing Scale-Helplessness; 





















n = 78 
 
RAD 
n = 68 
 
FM 
n = 61 
 
nBP 







(p< 0.05)  
 










F (3/ 302) = 3.08* 
 
FM < TNP 
Sex, n (%)       
Female 47.4% 64.8% 82.5% 67.7% X
2  
(3) =  18.40*** ─ 
Pain history 
(years) 
7.6±5.1 7.3±5.6 9.5±6.5 8.9±8 F (3/ 305) = 1.75
†
 ─ 
       
NRS (M ± SD) 6.63±1.9 6.83±1.7 6.91±1.6 6.63±2.0 F (3/ 300) = .47
†
 ─ 
MPSS (M ± SD) 8.72±1.1 8.92±1.3 9.28±1.1 8.45±1.1 F (3/ 288) = 6.11*** nBP, TNP < FM 
PDQ (M ± SD) 19.01±7.2 20.32±6.5 19.50±6.9 13.27±6.6 F (3/ 299) = 19.42*** nBP < RAD, TNP, FM 
PCS-H (M ± SD) 12.06±5.2 10.93±5.7 13.63±4.9 12.33±5.2 F (3/ 231) = 1.84
†
 ─ 
CPAQ (M ± SD) 32.93±10.1 32.06±9.9 27.41±10.8 29.64±9.6 F (3/ 227) = 2.46
†
 ─ 
ADS-K (M ± SD) 15.63±8.9 14.52±9.6 21.93±10.1 17.34±8.8 F (3/ 230) = 4.64** RAD, TNP < FM 




Table 2. Multinominal logistic regression analysis; Odds Ratio, Confidence Intervals (95%), Significance and 
Nagelkerke 
                       
Diagnostic group (Ref = typical neuropathic pain) 
Level of self-reported 














 0.24 (0.10-0.55)**  
0.19*** 
 
High level  (M=3.36)
a




 0.05 (0.01-0.16)*** 
Ref: Low level (M=1.38)
a
    
Note.; 
a
Mean score of the self-reported neuropathic sensory symptoms (sum of the 7 sensory symptoms/ 7); RAD = radiculopathy; 



































Table 3. Means and SDs of various pain and psychological variables in patients with different levels of self-
reported neuropathic sensory symptoms across the four diagnostic groups (clustering 1) 
 
  “Cluster 1” 




















F (df) Post-hoc 
“LSD” 





NRS (M±SD) 5.87±2.85 6.41±1.75 6.96±1.92 1.15 (2,70)
†
 ─ 
MPSS (M±SD) 8.25±1.48 8.73±1.05 8.77±1.18 0.68 (2,70)
†
 ─ 
PCS-H (M±SD) 11.50±2.00 12.86±5.70 10.46±5.70 .88 (2,40)
†
 ─ 
CPAQ (M±SD) 33.80±10.29 33.95±10.21 32.64±11.18 0.07 (2,37)
†
 ─ 
ADS-K (M±SD) 15.00±1.41 16.72±9.72 15.21±10.41 0.16 (2,40)
†
 ─ 
       
Radiculopathy 
(RAD) 
NRS (M±SD) 6.62±1.59 6.68±1.77 7.20±1.47 0.69 (2,63)
†
 ─ 
MPSS (M±SD) 8.42±0.97 8.89±1.44 9.26±1.32 1.03 (2,61)
†
 ─ 
PCS-H (M±SD) 9.33±3.82 10.80±5.71 12.23±6.21 0.66 (2,55)
†
 ─ 
CPAQ (M±SD) 37.66±12.45 33.17±9.30 27.58±10.11 2.93 (2,55)
†
 ─ 
ADS-K (M±SD) 14.20±4.65 12.82±9.33 18.94±10.59 2.39 (2,54)
†
 ─ 
       
Fibromyalgia 
(FM) 
NRS (M±SD) 6.28±1.60 6.53±1.66 7.50±1.44 3.03 (2,55)
†
 ─ 
MPSS (M±SD) 9.28±0.75 8.92±1.23 9.70±1.08 3.04 (2,55)
 †
 ─ 
PCS-H (M±SD) 10.80±2.16 13.40±5.47 16.37±4.71 2.11 (2,25)
†
 ─ 
CPAQ (M±SD) 31.40±11.80 27.60±10.97 26.14±11.52 0.33 (2,24)
†
 ─ 
ADS-K (M±SD) 17.60±10.26 20.53±9.54 26.12±10.93 1.28 (2,25)
†
 ─ 




NRS (M±SD) 6.06±1.82 6.89±2.12 8.00±2.23 3.76 (2,95)
*
 1 < 3 
MPSS (M±SD) 8.33±1.16 8.42±1.05 9.14±1.06 1.60 (2,86)
†
 ─ 
PCS-H (M±SD) 11.04±5.99 12.93±4.28 16.00±4.20 3.50 (2,95)* 1 < 3 
CPAQ (M±SD) 32.75±11.47 27.91±6.85 23.14±7.58 5.00 (2,95)** (2,3) < 1 
ADS-K (M±SD) 15.29±8.53 17.61±7.79 25.85±10.63 4.97 (2,95)** (1,2) < 3 
       
Total 
 
NRS (M±SD) 6.19±1.93 6.65±1.86 7.25±1.68 6.09 (2,293)** (1,2) < 3 
MPSS (M±SD) 8.44±1.15 8.72±1.21 9.22±1.22 7.76 (2,281)*** (1,2) < 3 
PCS-H (M±SD) 10.96±5.18 12.35±5.19 13.02±5.93 2.22 (2,224)
†
 ─ 
CPAQ (M±SD) 33.26±10.91 30.50±9.15 28.06±10.60 3.57 (2,220)* 3 < 1 
ADS-K (M±SD) 15.38±7.77 16.41±9.11 20.17±11.27 3.82 (2,223)* (1,2) < 3 
Note.
a
Mean score of the self-reported neuropathic sensory symptoms (sum of the 7 sensory symptoms/ 7); TNP = typical 
neuropathic pain; RAD = radiculopathy; FM = fibromyalgia; nBP = nociceptive back pain; NRS, Numeric Rating Scale; MPSS, Mainz 
Pain Staging System; PCS-H, Pain Catastrophizing Scale-Helplessness; CPAQ, Chronic Pain Acceptance Questionnaire; ADS-K, 



















































































































































































TNP 26%; RAD 12.9%; FM 15%; nBP 13.3% 
NRS= 6.68±1.8  MPSS= 8.83±1.3 
PCS-H= 12.32±6.0  CPAQ= 32.55±10.0 
ADS-K= 16.10±10.5 
Cluster 2 
TNP 14.3%; RAD 28.6%; FM 38.3%; nBP 44.9% 
NRS= 6.67±1.8  MPSS= 8.59±1.1 
PCS-H= 11.75±5.2  CPAQ= 29.83±9.0 




TNP 40.3%; RAD 42.9%; FM 33.3%; nBP 39.8% 
NRS= 6.68±1.9  MPSS= 8.97±1.2 
PCS-H= 12.09±5.0  CPAQ= 31.12±10.4 




TNP 19.5%; RAD 15.7%; FM 13.3%; nBP 2% 
NRS= 6.86±1.7  MPSS= 8.60±1.1 
PCS-H= 12.53±5.8  CPAQ= 29.3±12.4 
ADS-K= 15.15±10.0 
 
Figure 1. Subgroups of chronic pain patients with distinct patterns of neuropathic sensory symptoms using 
the Pain DETECT Questionnaire (clustering 2) 
Note: Vertical axis: adjusted scores of neuropathic sensory symptoms, Horizontal axis marked as 0: average of 
seven adjusted scores of neuropathic sensory symptoms; TNP: typical neuropathic pain; RAD: radiculopathy; FM: 
fibromyalgia; nBP: nociceptive back pain; NRS, Numeric Rating Scale; MPSS, Mainz Pain Staging System; PCS-H, 
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